10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2023

OR

☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934

For the transition period from ______ to ______

Commission File Number: 000-23329

Charles & Colvard, Ltd.

(Exact name of registrant as specified in its charter)

North Carolina	56-1928817
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

170 Southport Drive Morrisville, North Carolina	27560
(Address of principal executive offices)	(Zip Code)

(919) 468-0399

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value per share	CTHR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    ☒    No    ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes    ☒    No    ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    ☐    No    ☒

As of April 28, 2023, there were 30,523,705 shares of the registrant’s common stock, no par value per share, outstanding.

CHARLES & COLVARD, LTD.

FORM 10-Q

For the Quarterly Period Ended March 31, 2023

TABLE OF CONTENTS

		Page Number
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and June 30, 2022	1
	Condensed Consolidated Statements of Operations (unaudited) for the three and nine months ended March 31, 2023 and 2022	2
	Condensed Consolidated Statements of Changes in Shareholders’ Equity (unaudited) for the three and nine months ended March 31, 2023 and 2022	3
	Condensed Consolidated Statements of Cash Flows (unaudited) for the nine months ended March 31, 2023 and 2022	4
	Notes to Condensed Consolidated Financial Statements (unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
Item 6.	Exhibits	35
	Signatures	36

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

CHARLES & COLVARD, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2023 (unaudited)			June 30, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	10,914,584		$	15,668,361
Restricted cash		5,056,044			5,510,979
Accounts receivable, net		933,553			2,220,816
Inventory, net		7,889,917			11,024,276
Note receivable		-			250,000
Prepaid expenses and other assets		883,814			1,190,012
Total current assets		25,677,912			35,864,444
Long-term assets:
Inventory, net		25,439,369			22,488,524
Property and equipment, net		2,317,738			1,901,176
Intangible assets, net		301,310			265,730
Operating lease right-of-use assets		2,336,334			2,787,419
Deferred income taxes, net		-			5,851,904
Note receivable		250,000			-
Other assets		50,387			49,658
Total long-term assets		30,695,138			33,344,411
TOTAL ASSETS	$	56,373,050		$	69,208,855
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	3,116,810		$	4,401,229
Operating lease liabilities, current portion		874,177			856,571
Accrued expenses and other liabilities		1,143,192			1,546,483
Total current liabilities		5,134,179			6,804,283
Long-term liabilities:
Noncurrent operating lease liabilities		2,251,581			2,846,805
Total long-term liabilities		2,251,581			2,846,805
Total liabilities		7,385,760			9,651,088
Commitments and contingencies (Note 9)
Shareholders’ equity:
Common stock, no par value; 50,000,000 shares authorized; 30,912,108 shares issued and 30,523,705 shares outstanding at March 31, 2023 and 30,778,046 shares issued and 30,747,759 shares outstanding at June 30, 2022		57,242,211			57,242,211
Additional paid-in capital		26,165,810			25,956,491
Treasury stock, at cost, 388,403 shares and 30,287 shares at March 31, 2023 and June 30, 2022, respectively		(489,979	)		(38,164	)
Accumulated deficit		(33,930,752	)		(23,602,771	)
Total shareholders’ equity		48,987,290			59,557,767
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	56,373,050		$	69,208,855

See Notes to Condensed Consolidated Financial Statements.

1

CHARLES & COLVARD, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended March 31,						Nine Months Ended March 31,
	2023			2022			2023			2022
Net sales	$	6,641,799		$	9,751,835		$	24,382,003		$	33,785,281
Costs and expenses:
Cost of goods sold		4,493,125			5,296,530			14,650,910			17,347,026
Sales and marketing		3,267,436			2,932,587			10,715,066			9,741,774
General and administrative		1,053,357			1,106,850			3,654,788			3,880,684
Total costs and expenses		8,813,918			9,335,967			29,020,764			30,969,484
(Loss) Income from operations		(2,172,119	)		415,868			(4,638,761	)		2,815,797
Other income (expense):
Interest income		69,159			1,120			168,935			1,964
Loss on foreign currency exchange		-			-			-			(34	)
Total other income (expense), net		69,159			1,120			168,935			1,930
(Loss) Income before income taxes		(2,102,960	)		416,988			(4,469,826	)		2,817,727
Income tax expense		(6,293,048	)		(78,480	)		(5,858,155	)		(484,582	)
Net (loss) income	$	(8,396,008	)	$	338,508		$	(10,327,981	)	$	2,333,145
Net (loss) income per common share:
Basic	$	(0.28	)	$	0.01		$	(0.34	)	$	0.08
Diluted	$	(0.28	)	$	0.01		$	(0.34	)	$	0.07
Weighted average number of shares used in computing net (loss) income per common share:
Basic		30,344,954			30,484,897			30,387,303			30,286,195
Diluted		30,344,954			31,268,410			30,387,303			31,271,677

See Notes to Condensed Consolidated Financial Statements.

2

CHARLES & COLVARD, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(unaudited)

	Nine Months Ended March 31, 2023
	Common Stock
	Number of Shares			Amount		Additional Paid-in Capital		Treasury Stock			Accumulated Deficit			Total Shareholders’ Equity
Balance at June 30, 2022		30,747,759		$	57,242,211	$	25,956,491	$	(38,164	)	$	(23,602,771	)	$	59,557,767
Stock-based compensation		-			-		96,232		-			-			96,232
Cancellation of restricted stock		(44,688	)		-		-		-			-			-
Repurchases of common stock		(358,116	)		-		-		(451,815	)		-			(451,815	)
Net loss		-			-		-		-			(890,192	)		(890,192	)
Balance at September 30, 2022		30,344,955			57,242,211		26,052,723		(489,979	)		(24,492,963	)		58,311,992
Stock-based compensation		-			-		78,493		-			-			78,493
Issuance of restricted stock		178,750			-		-		-			-			-
Net loss		-			-		-		-			(1,041,781	)		(1,041,781	)
Balance at December 31, 2022		30,523,705			57,242,211		26,131,216		(489,979	)		(25,534,744	)		57,348,704
Stock-based compensation		-			-		34,594		-			-			34,594
Net loss		-			-		-		-			(8,396,008	)		(8,396,008	)
Balance at March 31, 2023		30,523,705		$	57,242,211	$	26,165,810	$	(489,979	)	$	(33,930,752	)	$	48,987,290

	Nine Months Ended March 31, 2022
	Common Stock
	Number of Shares		Amount		Additional Paid-in Capital			Treasury Stock		Accumulated Deficit			Total Shareholders’ Equity
Balance at June 30, 2021		29,913,095	$	56,057,109	$	25,608,593		$	-	$	(25,976,686	)	$	55,689,016
Stock-based compensation		-		-		279,407			-		-			279,407
Issuance of restricted stock		242,725		-		-			-		-			-
Stock option exercises		183,637		397,112		(139,742	)		-		-			257,370
Net income		-		-		-			-		827,025			827,025
Balance at September 30, 2021		30,339,457		56,454,221		25,748,258			-		(25,149,661	)		57,052,818
Stock-based compensation		-		-		199,004			-		-			199,004
Stock option exercises		255,590		447,877		(159,329	)		-		-			288,548
Net income		-		-		-			-		1,167,612			1,167,612
Balance at December 31, 2021		30,595,047		56,902,098		25,787,933			-		(23,982,049	)		58,707,982
Stock-based compensation		-		-		198,523			-		-			198,523
Stock option exercises		93,749		164,045		(59,046	)		-		-			104,999
Net income		-		-		-			-		338,508			338,508
Balance at March 31, 2022		30,688,796	$	57,066,143	$	25,927,410		$	-	$	(23,643,541	)	$	59,350,012

See Notes to Condensed Consolidated Financial Statements.

3

CHARLES & COLVARD, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	Nine Months Ended March 31,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$	(10,327,981	)	$	2,333,145
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization		477,285			350,198
Stock-based compensation		209,319			676,934
(Recovery of) Provision for uncollectible accounts		(18,000	)		26,000
Provision for (Recovery of) sales returns		59,000			(25,000	)
Inventory write-downs		119,000			232,000
Provision for accounts receivable discounts		42			3,269
Deferred income taxes		5,851,904			483,168
Changes in operating assets and liabilities:
Accounts receivable		1,246,221			92,264
Inventory		64,514			(3,562,704	)
Prepaid expenses and other assets, net		756,554			640,843
Accounts payable		(1,284,419	)		356,311
Accrued income taxes		-			1,414
Accrued expenses and other liabilities		(980,909	)		(504,862	)
Net cash (used in) provided by operating activities		(3,827,470	)		1,102,980
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment		(884,030	)		(1,250,296	)
Payments for intangible assets		(45,397	)		(38,867	)
Net cash used in investing activities		(929,427	)		(1,289,163	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchases of common stock		(451,815	)		-
Stock option exercises		-			650,917
Net cash (used in) provided by financing activities		(451,815	)		650,917
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH		(5,208,712	)		464,734
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD		21,179,340			21,446,951
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD	$	15,970,628		$	21,911,685
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	$	5,900		$	-

See Notes to Condensed Consolidated Financial Statements.

4

CHARLES & COLVARD, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. DESCRIPTION OF BUSINESS

Charles & Colvard, Ltd. (the “Company”), a North Carolina corporation, was founded in 1995. The Company manufactures, markets, and distributes Charles & Colvard Created Moissanite^® (hereinafter referred to as moissanite or moissanite jewels) and finished jewelry featuring moissanite, including Forever One™, the Company’s premium moissanite gemstone brand, for sale in the worldwide fine jewelry market. The Company also markets and distributes Caydia^® lab grown diamonds and finished jewelry featuring lab grown diamonds for sale in the worldwide fine jewelry market. Moissanite, also known by its chemical name silicon carbide (“SiC”), is a rare mineral first discovered in a meteorite crater. Because naturally occurring SiC crystals are too small for commercial use, larger crystals must be grown in a laboratory. Lab grown diamonds are also grown using technology that replicates the natural diamond growing process. The only differentiation between that of a lab grown diamond and a mined diamond is its origin. The result is a man-made diamond that is chemically, physically, and optically the same as those grown beneath the earth’s surface.

The Company sells loose moissanite jewels, loose lab grown diamonds, and finished jewelry featuring both moissanite and lab grown diamonds at wholesale prices to distributors, manufacturers, retailers, and designers, including some of the largest distributors and jewelry manufacturers in the world. The Company’s finished jewelry and loose moissanite jewels and lab grown diamonds that are mounted into fine jewelry by other manufacturers are sold at retail outlets and via the Internet. The Company sells at retail prices to end-consumers through its own Charles & Colvard Signature Showroom, which opened in October 2022, and also through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, third-party online marketplaces, drop-ship, and other pure-play, exclusively e-commerce outlets. The Company also sells at discount retail prices to end-consumers through moissaniteoutlet.com, LLC, a wholly owned operating subsidiary of charlesandcolvard.com, LLC, and third-party online marketplaces.

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation – The accompanying unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. However, certain information or footnote disclosures normally included in complete financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q include all normal and recurring adjustments necessary for the fair statement of the results for the interim periods presented. The results for the nine months ended March 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2023 (“Fiscal 2023”).

The condensed consolidated financial statements as of March 31, 2023 and for the three and nine months ended March 31, 2023 and 2022 included in this Quarterly Report on Form 10-Q are unaudited. The balance sheet as of June 30, 2022 is derived from the audited financial statements as of that date. The accompanying statements should be read in conjunction with the audited financial statements and related notes contained in Item 8 of the Company’s Annual Report on Form 10-K (the “2022 Annual Report”) for the fiscal year ended June 30, 2022 filed with the SEC on September 2, 2022.

The accompanying condensed consolidated financial statements as of March 31, 2023, for the three and nine months ended March 31, 2023 and 2022, and as of the fiscal year ended June 30, 2022, include the accounts of the Company and its wholly owned subsidiaries charlesandcolvard.com, LLC, including its wholly-owned subsidiary, moissaniteoulet.com, LLC, which was formed and incorporated as of February 24, 2022; Charles & Colvard Direct, LLC; and Charles & Colvard (HK) Ltd., the Company’s Hong Kong subsidiary, which was entered into dormancy as of September 30, 2020 following its re-activation in December 2017. Charles & Colvard (HK) Ltd. previously became dormant in the second quarter of 2009 and has had no operating activity since 2008. Charles & Colvard Direct, LLC, had no operating activity during the nine-month periods ended March 31, 2023 or 2022. All intercompany accounts have been eliminated.

Significant Accounting Policies – In the opinion of the Company’s management, except as discussed below, the Company’s significant accounting policies used for the three and nine months ended March 31, 2023, are consistent with those used for the fiscal year ended June 30, 2022. Accordingly, please refer to Note 2 to the Consolidated Financial Statements in the 2022 Annual Report for the Company’s significant accounting policies.

5

Use of Estimates – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. As future events and their effects, including any impact of the COVID-19 pandemic and the related responses, cannot be fully determined with precision, actual results of operations, cash flow, and financial position could differ significantly from estimates. The most significant estimates impacting the Company’s condensed consolidated financial statements relate to valuation and classification of inventories, accounts receivable reserves, deferred tax assets (including deferred tax asset valuation allowances), stock-based compensation, and revenue recognition. Changes in estimates are reflected in the condensed consolidated financial statements in the period in which the change in estimate occurs.

Cash and Cash Equivalents – All highly liquid investments with an original maturity of three months or less from the date of purchase are considered to be cash equivalents.

Restricted Cash – In accordance with the terms of the Company’s cash collateralized $5.00 million credit facility from JPMorgan Chase Bank, N.A. (“JPMorgan Chase”), which expires by its terms on July 31, 2023, the Company is required to keep $5.05 million in a cash deposit account held by JPMorgan Chase. Such amount is held as security for the Company’s credit facility from JPMorgan Chase. Accordingly, this cash deposit held by JPMorgan Chase is classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s cash collateralized credit facility, see Note 10, “Debt.”

Pursuant to the terms and conditions of the Company’s broker-dealer agreement with Oppenheimer & Co., Inc. (“Oppenheimer”), with whom the Company has engaged to transact common stock share repurchases in connection with its stock repurchase program, the Company is required to maintain a funded liquid margin account held by Oppenheimer for the benefit of the Company. The purpose of this account is to fund the Company’s common stock purchases and any underlying transaction costs and fees. Depending upon the level and timing of stock repurchase activity, the funded margin account cash balance will fluctuate from time to time. At March 31, 2023 and June 30, 2022, cash in the amount of approximately $30 and approximately $461,000, respectively, was held by Oppenheimer. Such cash amount held by Oppenheimer was classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s stock repurchase program, see Note 11, “Shareholders’ Equity and Stock-Based Compensation.”

The reconciliation of cash, cash equivalents, and restricted cash, as presented on the Condensed Consolidated Statements of Cash Flows, consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Cash and cash equivalents	$	10,914,584	$	15,668,361
Restricted cash		5,056,044		5,510,979
Total cash, cash equivalents, and restricted cash	$	15,970,628	$	21,179,340

Reclassification – Certain amounts in the Company’s condensed consolidated financial statements as of June 30, 2022 have been reclassified to conform to current presentation, principally amounts presented in Note 7, “Accrued Expenses and Other Liabilities”, relating to the combination of accrued sales tax and accrued franchise taxes, which had previously been presented separately. These reclassifications had no impact on the Company’s condensed consolidated financial position or condensed consolidated results of operations as of or for the three and nine months ended March 31, 2023 and 2022 and as of June 30, 2022.

6

3. SEGMENT INFORMATION AND GEOGRAPHIC DATA

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making operating decisions and assessing performance as the source of the Company’s operating and reportable segments.

The Company manages its business through two operating and reportable segments based on its distribution channels to sell its product lines, loose jewels and finished jewelry: its “Online Channels” segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets; and its “Traditional” segment, which consists of wholesale and retail customers, including its own Charles & Colvard Signature Showroom. The accounting policies of the Online Channels segment and Traditional segment are the same as those described in Note 2, “Basis of Presentation and Significant Accounting Policies” of this Quarterly Report on Form 10-Q and in the Notes to the Consolidated Financial Statements in the 2022 Annual Report.

The Company evaluates the financial performance of its segments based on net sales; product line gross profit, or the excess of product line sales over product line cost of goods sold; and operating income. The Company’s product line cost of goods sold is defined as product cost of goods sold, excluding non-capitalized expenses from the Company’s manufacturing and production control departments, comprising personnel costs, depreciation, leases, utilities, and corporate overhead allocations; freight out; inventory write-downs; and other inventory adjustments, comprising costs of quality issues, and damaged goods.

The Company allocates certain general and administrative expenses between its Online Channels segment and its Traditional segment based on net sales and number of employees to arrive at segment operating income. Unallocated expenses remain in its Traditional segment.

Summary financial information by reportable segment for the periods presented is as follows:

	Three Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	4,130,314		$	1,190,987		$	5,321,301
Loose jewels		486,084			834,414			1,320,498
Total	$	4,616,398		$	2,025,401		$	6,641,799
Product line cost of goods sold
Finished jewelry	$	1,880,504		$	959,817		$	2,840,321
Loose jewels		197,145			448,114			645,259
Total	$	2,077,649		$	1,407,931		$	3,485,580
Product line gross profit
Finished jewelry	$	2,249,810		$	231,170		$	2,480,980
Loose jewels		288,939			386,300			675,239
Total	$	2,538,749		$	617,470		$	3,156,219
Operating loss	$	(999,028	)	$	(1,173,091	)	$	(2,172,119	)
Depreciation and amortization	$	47,876		$	120,509		$	168,385
Capital expenditures	$	14,202		$	252,545		$	266,747

7

	Three Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	5,720,197	$	1,700,394	$	7,420,591
Loose jewels		634,617		1,696,627		2,331,244
Total	$	6,354,814	$	3,397,021	$	9,751,835
Product line cost of goods sold
Finished jewelry	$	2,560,952	$	1,148,912	$	3,709,864
Loose jewels		229,714		784,272		1,013,986
Total	$	2,790,666	$	1,933,184	$	4,723,850
Product line gross profit
Finished jewelry	$	3,159,245	$	551,482	$	3,710,727
Loose jewels		404,903		912,355		1,317,258
Total	$	3,564,148	$	1,463,837	$	5,027,985
Operating income	$	350,276	$	65,592	$	415,868
Depreciation and amortization	$	52,613	$	59,374	$	111,987
Capital expenditures	$	28,145	$	446,445	$	474,590

	Nine Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	15,657,343		$	3,640,572		$	19,297,915
Loose jewels		1,657,369			3,426,719			5,084,088
Total	$	17,314,712		$	7,067,291		$	24,382,003
Product line cost of goods sold
Finished jewelry	$	7,296,812		$	2,335,540		$	9,632,352
Loose jewels		623,129			1,719,004			2,342,133
Total	$	7,919,941		$	4,054,544		$	11,974,485
Product line gross profit
Finished jewelry	$	8,360,531		$	1,305,032		$	9,665,563
Loose jewels		1,034,240			1,707,715			2,741,955
Total	$	9,394,771		$	3,012,747		$	12,407,518
Operating income	$	(1,954,975	)	$	(2,683,786	)	$	(4,638,761	)
Depreciation and amortization	$	167,769		$	309,516		$	477,285
Capital expenditures	$	173,810		$	710,220		$	884,030

8

	Nine Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	18,659,690	$	4,986,354	$	23,646,044
Loose jewels		2,388,584		7,750,653		10,139,237
Total	$	21,048,274	$	12,737,007	$	33,785,281
Product line cost of goods sold
Finished jewelry	$	7,705,127	$	3,043,196	$	10,748,323
Loose jewels		877,604		3,630,393		4,507,997
Total	$	8,582,731	$	6,673,589	$	15,256,320
Product line gross profit
Finished jewelry	$	10,954,563	$	1,943,158	$	12,897,721
Loose jewels		1,510,980		4,120,260		5,631,240
Total	$	12,465,543	$	6,063,418	$	18,528,961
Operating income	$	2,104,674	$	711,123	$	2,815,797
Depreciation and amortization	$	173,786	$	176,412	$	350,198
Capital expenditures	$	114,445	$	1,135,851	$	1,250,296

The Company does not allocate any assets to the reportable segments, and, therefore, no asset information is reported to the chief operating decision maker or disclosed in the financial information for each segment.

A reconciliation of the Company’s product line cost of goods sold to cost of goods sold as reported in the condensed consolidated financial statements is as follows:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023		2022			2023		2022
Product line cost of goods sold	$	3,485,580	$	4,723,850		$	11,974,485	$	15,256,320
Non-capitalized manufacturing and production control expenses		596,344		484,299			1,660,231		1,243,528
Freight out		216,817		294,143			851,171		976,855
Inventory write-downs		-		-			119,000		232,000
Other inventory adjustments		194,384		(205,762	)		46,023		(361,677	)
Cost of goods sold	$	4,493,125	$	5,296,530		$	14,650,910	$	17,347,026

9

The Company recognizes sales by geographic area based on the country in which the customer is based. Sales to international end consumers made through the Company’s transactional websites, charlesandcolvard.com and moissaniteoutlet.com, are included in international sales for financial reporting purposes. A portion of the Company’s Traditional segment sales made to international wholesale distributors represents products sold internationally that may be re-imported to U.S. retailers.

The following presents net sales by geographic area:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Net sales
United States	$	6,545,336	$	9,390,774	$	23,630,410	$	32,237,221
International		96,463		361,061		751,593		1,548,060
Total	$	6,641,799	$	9,751,835	$	24,382,003	$	33,785,281

4. FAIR VALUE MEASUREMENTS

Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability. The fair value hierarchy consists of three levels based on the reliability of inputs, as follows:

Level 1.  Quoted prices in active markets for identical assets and liabilities;

Level 2.  Inputs other than Level 1 quoted prices that are directly or indirectly observable; and

Level 3.  Unobservable inputs that are not corroborated by market data.

The Company evaluates assets and liabilities subject to fair value measurements on a recurring and non-recurring basis to determine the appropriate level to classify them for each reporting period. This determination requires significant judgments to be made by management of the Company. The financial instruments identified as subject to fair value measurements on a recurring basis are cash and cash equivalents, notes receivable, trade accounts receivable, and trade accounts payable. All financial instruments are reflected in the condensed consolidated balance sheets at carrying value, which approximates fair value due to the nature of these financial instruments. Assets that are measured at fair value on a non-recurring basis include property and equipment, leasehold improvements, and intangible assets comprising patents, license rights, and trademarks. These items are recognized at fair value when they are considered to be impaired. For the three and nine months ended March 31, 2023 and 2022, no impairment was recorded.

10

5. INVENTORIES

The Company’s total inventories, net of reserves, consisted of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Finished jewelry:
Raw materials	$	1,359,919	$	1,697,361
Work-in-process		716,494		1,260,728
Finished goods		13,045,604		12,100,910
Finished goods on consignment		2,266,501		2,135,856
Total finished jewelry	$	17,388,518	$	17,194,855
Loose jewels:
Raw materials	$	812,024	$	1,985,355
Work-in-process		8,980,285		8,485,713
Finished goods		5,519,936		5,454,266
Finished goods on consignment		251,693		303,491
Total loose jewels		15,563,938		16,228,825
Total supplies inventory		376,830		89,120
Total inventory	$	33,329,286	$	33,512,800

As of the dates presented, the Company’s total inventories, net of reserves, are classified as follows:

	March 31, 2023		June 30, 2022
Short-term portion	$	7,889,917	$	11,024,276
Long-term portion		25,439,369		22,488,524
Total	$	33,329,286	$	33,512,800

The Company’s work-in-process inventories include raw SiC crystals on which processing costs, such as labor and sawing, have been incurred; and components, such as metal castings and finished goods set with moissanite jewels, that have been issued to jobs in the manufacture of finished jewelry. The Company’s moissanite jewel manufacturing process involves the production of intermediary shapes, called “preforms,” that vary depending upon the expected size and shape of the finished jewel. To maximize manufacturing efficiencies, preforms may be made in advance of current finished inventory needs but remain in work-in-process inventories. As of March 31, 2023 and June 30, 2022, work-in-process inventories issued to active production jobs approximated $1.41 million and $2.76 million, respectively.

11

The Company’s moissanite and lab grown diamond jewels do not degrade in quality over time and inventory generally consists of the shapes and sizes most commonly used in the jewelry industry. In addition, approximately one-half of the Company’s jewel inventory is not mounted in finished jewelry settings and is therefore not subject to fashion trends. Product obsolescence is closely monitored and reviewed by management as of and for each financial reporting period.

The Company manufactures finished jewelry featuring moissanite and lab grown diamonds. Relative to loose moissanite jewels and lab grown diamonds, finished jewelry is more fashion-oriented and subject to styling trends that could render certain designs obsolete over time. The majority of the Company’s finished jewelry featuring moissanite and lab grown diamonds is held in inventory for resale and largely consists of such core designs as stud earrings, solitaire and three-stone rings, pendants, and bracelets that tend not to be subject to significant obsolescence risk due to their classic styling. In addition, the Company generally holds smaller quantities of designer-inspired and trend moissanite fashion jewelry that is available for resale through retail companies and through its Online Channels segment. The Company also carries a limited amount of inventory as part of its sample line that the Company uses in the selling process to its customers.

The Company’s continuing operating subsidiaries carry no net inventories, and inventory is transferred without intercompany markup from the parent entity as product line cost of goods sold when sold to the end consumer.

The Company’s inventories are stated at the lower of cost or net realizable value on an average cost basis. Each accounting period the Company evaluates the valuation and classification of inventories including the need for potential adjustments to inventory-related reserves, which include significant estimates by management, including the effect of market factors and sales trends. Changes to the Company’s inventory reserves and allowances are accounted for in the accounting period in which a change in such reserves and allowances is observed and deemed appropriate, including changes in management’s estimates used in the process to determine such reserves and valuation allowances.

6. NOTE RECEIVABLE

On March 5, 2021, the Company entered into a $250,000 convertible promissory note agreement (the “Convertible Promissory Note”), with an unrelated third-party strategic marketing partner. The Convertible Promissory Note is unsecured and was scheduled originally to mature on March 5, 2022. In February 2022, the Company entered into an amendment to the Convertible Promissory Note that was effective as of December 9, 2021 and changed the maturity date to September 30, 2022. Effective September 26, 2022, the Company further amended the Convertible Promissory Note (the “September 2022 Amendment”) and changed the maturity date to June 20, 2024 (the “Maturity Date”). Prior to the September 2022 Amendment, the Company accounted for the Convertible Promissory Note as a current note receivable within the accompanying condensed consolidated financial statements. However, in accordance with the terms of the September 2022 Amendment, the note receivable is classified as a noncurrent note receivable within the accompanying condensed consolidated financial statements as of March 31, 2023.

Interest is accrued at a simple rate of 0.14% per annum and will continue to accrue until the Convertible Promissory Note is converted in accordance with the conversion privileges contained within the Convertible Promissory Note or is repaid. Principal outstanding during an event of default accrues interest at the rate of 5% per annum. Prior to the September 2022 Amendment, accrued and unpaid interest on the Convertible Promissory Note was classified as a current asset and included in prepaid expenses and other assets in the accompanying condensed consolidated financial statements. In accordance with the terms of the September 2022 Amendment, accrued and unpaid interest on the Convertible Promissory Note is classified as a noncurrent asset and included in other noncurrent assets in the accompanying condensed consolidated financial statements as of March 31, 2023.

Subject to the borrower’s completion of a specified equity financing transaction (an “Equity Financing”) on or prior to the Maturity Date, the unpaid principal amount, including accrued and unpaid interest, automatically converts into equity units of the most senior class of equity securities issued to investors in the Equity Financing at the lesser of 80% of the per unit price of the units purchased by investors or the price equal to $33,500,000 divided by the aggregate number of outstanding units of the borrower immediately prior to the closing of the financing. Unless converted as provided in the Convertible Promissory Note, the principal amount, including accrued and unpaid interest, will, on the Maturity Date, at the Company’s option either (i) become due and payable to the Company, or (ii) convert into equity units at the specified conversion price in accordance with the terms of the Convertible Promissory Note.

12

7. ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Deferred revenue	$	434,132	$	452,866
Accrued compensation and related benefits		275,465		614,443
Accrued sales taxes and franchise taxes		233,351		341,706
Accrued cooperative advertising		200,243		137,467
Other accrued expenses		1		1
Total accrued expenses and other liabilities	$	1,143,192	$	1,546,483

8. INCOME TAXES

As of each reporting date, management considers new evidence, both positive and negative, that could impact the Company’s view with regard to future realization of deferred tax assets. During the three months ended March 31, 2023, management determined that due to the worsening global macro-economic conditions and heightened levels of inflation, including fears of recession, coupled with the effects from worldwide political unrest and the ongoing economic impact from the COVID pandemic, the risks associated with these conditions led management to conclude that it was not more likely than not the Company would have sufficient future taxable income to utilize its deferred tax assets. Additionally, the Company’s management determined that the positive evidence was no longer sufficient to offset available negative evidence, primarily as a result of the pre-tax operating losses incurred during the three- and nine-month periods ended March 31, 2023. Consequently, management established a full valuation allowance against the Company’s deferred tax assets, resulting in an income tax expense of approximately $6.29 million and $5.86 million for the three and nine months ended March 31, 2023, respectively. The Company recognized an income tax expense of approximately $78,000 and $485,000 for the three and nine months ended March 31, 2022, respectively.

The Company’s effective income tax rate reflects the effect of federal and state income taxes on earnings and the impact of differences in book and tax accounting arising primarily from the permanent tax benefits associated with stock-based compensation transactions during the quarter. Driven by the establishment of the valuation allowance during the quarter ended March 31, 2023, the Company’s effective tax rate for the nine month-period then ended was a negative 131.06%. For the nine months ended March 31, 2022, the Company’s effective tax rate was 17.20%.

13

9. COMMITMENTS AND CONTINGENCIES

Lease Arrangements

On December 9, 2013, the Company entered into a Lease Agreement, as amended on December 23, 2013, April 15, 2014, and January 29, 2021 (the “Lease Agreement”), for its corporate headquarters, which occupies approximately 36,350 square feet of office, storage and light manufacturing space and is classified as an operating lease for financial reporting purposes. The expiration date of the base term of the Lease Agreement is October 31, 2026 and the terms of the Lease Agreement contain no early termination provisions. Provided there is no outstanding uncured event of default under the Lease Agreement, the Company has an option to extend the lease term for a period of five years. The Company’s option to extend the term of the Lease Agreement must be exercised in writing on or before 270 days prior to expiration of the then-current term. If the option is exercised, the monthly minimum rent for each of the extended terms will be adjusted to the then prevailing fair market rate.

The Company took possession of the leased property on May 23, 2014, once certain improvements to the leased space were completed and did not have access to the property before this date. Upon execution of the third amendment to the Lease Agreement (the “Lease Amendment”) on January 29, 2021, the Lease Amendment included a rent abatement in the amount of approximately $214,000, which is reflected in the rent payments used in the calculation of the right-of-use (“ROU”) asset and lease liability once remeasured upon the execution of the Lease Amendment to extend the lease term. The Lease Amendment also included an allowance for leasehold improvements offered by the landlord in an amount not to exceed approximately $545,000. As of the quarter ended March 31, 2023, the Company has been reimbursed approximately $506,000 by the landlord for qualified leasehold improvements in accordance with the terms of the Lease Amendment. This reimbursement by the landlord reduced the remaining ROU asset by the same amount and is being recognized prospectively over the remaining term of the lease.

The Company has no other material operating leases and is not party to leases that would qualify for classification as a finance lease, variable lease, or short-term lease.

As of March 31, 2023, the Company’s balance sheet classifications of its leases are as follows:

Operating Leases:
Noncurrent operating lease ROU assets	$	2,336,334
Current operating lease liabilities	$	874,177
Noncurrent operating lease liabilities		2,251,581
Total operating lease liabilities	$	3,125,758

The Company’s total operating lease cost was approximately $193,000 for each of the three months ended March 31, 2023 and 2022. The Company’s total operating lease cost was approximately $578,000 and $596,000 for the nine months ended March 31, 2023 and 2022, respectively.

The Company’s estimated incremental borrowing rate used and assumed discount rate with respect to operating leases was 2.81% and the remaining operating lease term was 3.58 years.

14

As of March 31, 2023, Company’s remaining future payments under operating leases for each fiscal year ending June 30 are as follows:

2023	$	219,393
2024		893,660
2025		918,236
2026		943,487
2027		317,327
Total lease payments		3,292,103
Less: imputed interest		166,345
Present value of lease payments		3,125,758
Less: current lease liability		874,177
Total long-term lease liability	$	2,251,581

The Company makes cash payments for amounts included in the measurement of its lease liabilities. During the three months ended March 31, 2023 and 2022, cash paid for operating leases was approximately $237,000 and $160,000, respectively. During the nine months ended March 31, 2023 and 2022, cash paid for operating leases was approximately $704,000 and $330,000, respectively.

Purchase Commitments

On December 12, 2014, the Company entered into an exclusive supply agreement (the “Supply Agreement”) with Wolfspeed, Inc. (“Wolfspeed”). Under the Supply Agreement, subject to certain terms and conditions, the Company agreed to exclusively purchase from Wolfspeed, and Wolfspeed agreed to exclusively supply, 100% of the Company’s required SiC materials in quarterly installments that must equal or exceed a set minimum order quantity. The initial term of the Supply Agreement was scheduled to expire on June 24, 2018, unless extended by the parties.

Effective June 22, 2018, the Supply Agreement was amended to extend the expiration date to June 25, 2023. The Supply Agreement was also amended to (i) provide the Company with one option, subject to certain conditions, to unilaterally extend the term of the Supply Agreement for an additional two-year period following expiration of the initial term; (ii) establish a process by which Wolfspeed may begin producing alternate SiC material based on the Company’s specifications that will give the Company the flexibility to use the materials in a broader variety of its products; and (iii) permit the Company to purchase certain amounts of SiC materials from third parties under limited conditions.

Effective June 30, 2020, the Supply Agreement was further amended to extend the expiration date to June 29, 2025, which may be extended again by mutual agreement of the parties. The Supply Agreement was also amended to, among other things, (i) spread the Company’s total purchase commitment under the Supply Agreement in the amount of approximately $52.95 million over the term of the Supply Agreement, as amended; (ii) establish a process by which Wolfspeed has agreed to accept purchase orders in excess of the agreed-upon minimum purchase commitment, subject to certain conditions; and (iii) permit the Company to purchase revised amounts of SiC materials from third parties under limited conditions.

The Company’s total purchase commitment under the Supply Agreement, as amended, until June 2025 is approximately $52.95 million, of which approximately $24.75 million remains to be purchased as of March 31, 2023. Over the life of the Supply Agreement, as amended, the Company’s future minimum annual purchase commitments of SiC crystals range from approximately $4.00 million to $10.00 million each year.

During the nine months ended March 31, 2023 and 2022, the Company purchased approximately $1.80 million and $4.49 million, respectively, of SiC crystals from Wolfspeed pursuant to the terms of the Supply Agreement, as amended. The Company has made no purchases of SiC crystals during the six-month period ended March 31, 2023 while currently in discussions regarding the terms of the Supply Agreement.

15

Inflation

Heightened levels of inflation and the potential worsening of macro-economic conditions present a risk for the Company, its suppliers, and the stability of the broader retail and e-commerce industry. During the first nine months of Fiscal 2023, the Company has experienced impacts to its labor and overhead rates and suppliers have signaled inflation related cost pressures, which is expected to flow through to the Company’s costs and pricing. While the Company has seen adverse impact from inflation on its financial results in the first nine months of Fiscal 2023, if inflation remains at current levels for an extended period, or increases, and the Company is unable to successfully mitigate the impact, the Company’s costs are likely to continue to increase, resulting in further pressure on its revenues, margins, and cash flows. In addition, inflation and the increases in the cost of borrowing from rising interest rates could constrain the overall purchasing power of the Company’s customers for its products and services, in particular in the near term to the extent inflation assumptions are less than current inflationary pressures.

10. DEBT

Line of Credit

Effective July 7, 2021, the Company obtained from JPMorgan Chase a $5.00 million cash collateralized line of credit facility (the “JPMorgan Chase Credit Facility”). The JPMorgan Chase Credit Facility may be used for general corporate and working capital purposes, including permitted acquisitions and certain additional indebtedness for borrowed money, installment obligations, and obligations under capital and operating leases. The JPMorgan Chase Credit Facility is secured by a cash deposit in the amount of $5.05 million held by JPMorgan Chase as collateral for the line of credit facility and was scheduled to mature on July 31, 2022. Effective July 28, 2022, the JPMorgan Chase Credit Facility was amended to, among other things, extend the maturity date to July 31, 2023, and append the Company’s obligations under the JPMorgan Chase Credit Facility to be guaranteed by the Company’s wholly owned subsidiaries, Charles & Colvard Direct, LLC, charlesandcolvard.com, LLC, and moissaniteoutlet.com, LLC.

Each advance under the JPMorgan Chase Credit Facility, as amended, accrues interest at a rate equal to the sum of JPMorgan Chase’s monthly secured overnight financing rate (“SOFR rate”) to which JPMorgan Chase is subject with respect to the adjusted SOFR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum and an unsecured to secured interest rate adjustment of 0.10% per annum. Prior to its amendment, each advance under the JPMorgan Chase Credit Facility would have accrued interest at a rate equal to JPMorgan Chase’s monthly LIBOR rate multiplied by a statutory reserve rate for eurocurrency funding to which JPMorgan Chase is subject with respect to the adjusted LIBOR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum. Interest is calculated monthly on an actual/360-day basis and payable monthly in arrears. Principal outstanding during an event of default, at JPMorgan Chase’s option, accrues interest at a rate of 3.00% per annum in excess of the above rate. Any advance may be prepaid in whole or in part without penalty at any time.

As of March 31, 2023, the Company had not borrowed against the JPMorgan Chase Credit Facility and had no outstanding debt as of the period then ended.

11. SHAREHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION

Repurchases of Common Stock 

Pursuant to authority granted by the Company’s Board of Directors on April 29, 2022, the Company can repurchase up to approximately $5.00 million in shares outstanding of the Company’s common stock over the three-year period ending April 29, 2025. Pursuant to the terms of the repurchase authorization, the common stock share repurchases are generally at the discretion of the Company’s management. As the Company repurchases its common shares, which have no par value, the Company reports such shares held as treasury stock in the accompanying condensed consolidated balance sheets with the purchase price recorded within treasury stock.

During the nine-month period ended March 31, 2023, the Company repurchased 358,116 shares of the Company’s common stock for an aggregate price of $451,815 pursuant to the repurchase authorization. The Company repurchased no shares of the Company’s common stock during the three-month period ended March 31, 2023.

Dividends

The Company has paid no cash dividends during the current fiscal year through March 31, 2023.

16

Stock-Based Compensation

The following table summarizes the components of the Company’s stock-based compensation included in net income for the periods presented:

	Three Months Ended March 31,							Nine Months Ended March 31,
	2023				2022			2023			2022
Employee stock options		$	63,383			$	60,045		$	185,585		$	187,059
Restricted stock awards			(28,789	)			138,478			23,734			489,875
Totals		$	34,594			$	198,523		$	209,319		$	676,934

No stock-based compensation was capitalized as a cost of inventory during the three and nine months ended March 31, 2023 and 2022.

Stock Options –The following is a summary of the stock option activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Exercise Price
Outstanding, June 30, 2022		1,658,803		$	1.32
Granted		270,787		$	1.02
Forfeited		(22,004	)	$	2.01
Expired		(3,663	)	$	1.01
Outstanding, March 31, 2023		1,903,923		$	1.27

The weighted average grant date fair value of stock options granted during the nine months ended March 31, 2023 and 2022 was approximately $0.59 and $1.37, respectively. The total fair value of stock options that vested during the nine months ended March 31, 2023 and 2022 was approximately $225,000 and $188,000, respectively.

The following table summarizes information about stock options outstanding at March 31, 2023:

Options Outstanding						Options Exercisable						Options Vested or Expected to Vest
Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price
	1,903,923		6.61	$	1.27		1,440,913		5.81	$	1.24		1,859,855		6.56	$	1.26

As of March 31, 2023, the unrecognized stock-based compensation expense related to unvested stock options was approximately $256,000, which is expected to be recognized over a weighted average period of approximately 18 months.

The aggregate intrinsic value of stock options outstanding, exercisable, and vested or expected to vest at March 31, 2023 and 2022 was approximately $101,000 and $973,000, respectively. These amounts are before applicable income taxes and represent the closing market price of the Company’s common stock at March 31, 2023 less the grant price, multiplied by the number of stock options that had a grant price that is less than the closing market price. These values represent the amount that would have been received by the optionees had these stock options been exercised on that date. During the nine months ended March 31, 2022, the aggregate intrinsic value of stock options exercised was approximately $829,000. During the nine months ended March 31, 2022, the total estimated tax benefit associated with certain stock options that were exercised was approximately $93,000. No stock options were exercised during the nine-month period ended March 31, 2023.

17

Restricted Stock

The following is a summary of the restricted stock activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Grant Date Fair Value
Unvested, June 30, 2022		178,750		$	2.75
Granted		178,750		$	0.97
Vested		(134,063	)		2.75
Cancelled		(44,687	)	$	2.75
Unvested, March 31, 2023		178,750		$	0.97

The unvested restricted shares as of March 31, 2023 are all performance-based restricted shares and were scheduled to vest, subject to achievement of the underlying performance goals, in July 2023. However, during the quarter ended March 31, 2023, it was determined that none of the underlying performance-based targets related to the unvested restricted shares would be achieved for Fiscal 2023 and management concluded that none of the restricted shares would vest. Accordingly, the underlying expected forfeiture rates were adjusted to reflect the change in estimate. In addition, the benefit in stock-based compensation expense from the reversal of previously recorded stock-based compensation on these performance-based awards related to the unvested restricted shares was recognized in the current quarter ended March 31, 2023. As of March 31, 2023, the estimated unrecognized stock-based compensation expense related to unvested restricted shares subject to achievement of performance goals was approximately $173,000, none of which is expected to be recognized over the weighted average period of approximately four months.

12. NET (LOSS) INCOME PER COMMON SHARE

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the periods. Diluted net income per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options and unvested restricted shares that are computed using the treasury stock method. Anti-dilutive stock awards consist of stock options that would have been anti-dilutive in the application of the treasury stock method.

The following table reconciles the differences between the basic and diluted net (loss) income per share presentations:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023			2022		2023			2022
Numerator:
Net (loss)income	$	(8,396,008	)	$	338,508	$	(10,327,981	)	$	2,333,145
Denominator:
Weighted average common shares outstanding:
Basic		30,344,954			30,484,897		30,387,303			30,286,195
Effect of dilutive securities		-			783,513		-			985,482
Diluted		30,344,954			31,268,410		30,387,303			31,271,677
Net (loss) income per common share:
Basic	$	(0.28	)	$	0.01	$	(0.34	)	$	0.08
Diluted	$	(0.28	)	$	0.01	$	(0.34	)	$	0.07

For the three and nine months ended March 31, 2023, stock options to purchase approximately 1.90 million shares were excluded from the computation of diluted net loss per common share because the effect of inclusion of such amounts would be anti-dilutive to net loss per common share. For the three and nine months ended March 31, 2022, stock options to purchase approximately 975,000 shares and 773,000 shares, respectively, were excluded from the computation of diluted net income per common share for each period presented herein. These shares were excluded from the computation of diluted net income per common share because the exercise price of the stock options for the period presented herein was greater than the average market price of the common shares or the effect of inclusion of such amounts would be anti-dilutive to net income per common share. Approximately 179,000 shares of unvested restricted stock are excluded from the computation of basic net (loss) income and diluted net (loss) income per common share as of both March 31, 2023 and 2022 because the shares are performance-based and the underlying conditions had not been met as of the periods presented herein.

18

13. MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash on deposit and cash equivalents held with banks and trade accounts receivable. The Company places cash deposits with federally insured financial institutions and maintains its cash at banks and financial institutions it considers to be of high credit quality. However, the Company’s cash deposits may at times exceed the Federal Deposit Insurance Corporation’s insurable limits. Accordingly, balances in excess of federally insured limitations may not be insured. The Company has not experienced losses on these accounts, and management believes that the Company is not exposed to significant risks on such accounts.

Trade receivables potentially subject the Company to credit risk. Payment terms on trade receivables for the Company’s Traditional segment customers are generally between 30 and 90 days, though it may offer extended terms with specific customers and on significant orders from time to time. The Company extends credit to its customers based upon a number of factors, including an evaluation of the customer’s financial condition and credit history that is verified through trade association reference services, the customer’s payment history with the Company, the customer’s reputation in the trade, and/or an evaluation of the Company’s opportunity to introduce its moissanite jewels or finished jewelry featuring moissanite and lab grown diamonds to new or expanded markets. Collateral is not generally required from customers. The need for an allowance for doubtful accounts is determined based upon factors surrounding the credit risk of specific customers, historical trends, and other information. For additional information regarding the Company’s measurement and disclosure of credit losses on financial assets, including trade accounts receivable, see Note 4, “Fair Value Measurements.”

At times, a portion of the Company’s accounts receivable will be due from customers that have individual balances of 10% or more of the Company’s total gross accounts receivable.

The following is a summary of customers that represent 10% or more of total gross accounts receivable as of the dates presented:

	March 31, 2023			June 30, 2022
Customer A		24	%		20	%
Customer B		18	%		29	%
Customer C		15	%		**	%
Customer D		*	%		13	%

* Customer D did not have individual balances that represented 10% or more of total gross accounts receivable as of March 31, 2023.

** Customer C did not have individual balances that represented 10% or more of total gross accounts receivable as of June 30, 2022.

A significant portion of sales is derived from certain customer relationships. The following is a summary of customers that represent greater than or equal to 10% of total net sales for the periods presented:

	Three Months Ended March 31,						Nine Months Ended March 31,
	2023			2022			2023			2022
Customer A		13	%		13	%		14	%		15	%

14. SUBSEQUENT EVENT

As previously disclosed, on December 19, 2022, management received notice from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq’s listing requirements because the minimum bid price of its common stock on The Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days. In accordance with the Nasdaq’s listing requirements, the Company had 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement.

On April 20, 2023, the Company’s management received a letter from the Nasdaq Listing Qualifications Department notifying the Company that the minimum bid price of its common stock was $1.00 per share or greater for at least the last 10 consecutive business days. Accordingly, the Company has regained compliance with the Nasdaq minimum bid price requirement and the matter is now closed.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Statements expressing expectations regarding our future and projections relating to products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as “may,” “will,” “should,” “could,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “continue,” and similar words, although some forward-looking statements are expressed differently.

All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management’s current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, the following:

1. Our business and our results of operations could be materially adversely affected as a result of general economic and market conditions;

2. Our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives;

3. We face intense competition in the worldwide gemstone and jewelry industry;

4. Our information technology, or IT, infrastructure, and our network may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events;

5. Constantly evolving privacy regulatory regimes are creating new legal compliance challenges;

6. We are subject to certain risks due to our international operations, distribution channels and vendors;

7. Our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis;

8. We are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products;

9. We may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation;

10. Seasonality of our business may adversely affect our net sales and operating income;

11. The effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain;

12. Our operations could be disrupted by natural disasters;

13. Sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control;

14. Our current customers may potentially perceive us as a competitor in the finished jewelry business;

15. We depend on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed;

16. If the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected;

17. Governmental regulation and oversight might adversely impact our operations;

18. The execution of our business plans could significantly impact our liquidity;

19. The financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results;

20. Negative or inaccurate information on social media could adversely impact our brand and reputation;

21. We rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business;

22. We may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business;

23. Environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations;

24. If we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer;

25. Our failure to maintain compliance with The Nasdaq Stock market’s continued listing requirements could result in the delisting of our common stock;

26. Some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; and

27. We cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term stockholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance.

20

Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.

The following discussion is designed to provide a better understanding of our unaudited condensed consolidated financial statements, including a brief discussion of our business and products, key factors that impacted our performance, and a summary of our operating results. This information should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and the consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022, or the 2022 Annual Report. Historical results and percentage relationships related to any amounts in the condensed consolidated financial statements are not necessarily indicative of trends in operating results for future periods.

Overview

Our Mission

At Charles & Colvard, Ltd., our mission is to provide a more conscious and conflict-free fine jewelry experience for our customers. We are dedicated to blazing a more brilliant path forward with our Made, Not Mined^™ gemstones and committed to creating fine jewelry with a conscience.

About Charles & Colvard

Charles & Colvard, Ltd., a North Carolina corporation founded in 1995 (which may be referred to as Charles & Colvard, we, us, or our) is a globally recognized fine jewelry company specializing in lab created gemstones. We manufacture, market, and distribute Charles & Colvard Created Moissanite^® (which we refer to as moissanite or moissanite jewels) and in September 2020, we announced our expansion into the lab grown diamond market with the launch of Caydia^®, an exclusive brand of premium lab grown diamonds. We offer gemstones and finished jewelry featuring our proprietary moissanite jewels and premium lab grown diamonds for sale in the worldwide fine jewelry market. Charles & Colvard is the original source of created moissanite, and in 2015, we debuted Forever One^™, our premium moissanite gemstone brand. As an e-commerce and multi-channel destination for fine jewelry featuring lab grown gemstones, we believe that the addition of lab grown diamonds is a natural progression for the Charles & Colvard brand.

We sell loose moissanite jewels, lab grown diamonds, and finished jewelry set with these gems through two operating segments: our Online Channels segment, which encompasses our digital properties components, comprised of our charlesandcolvard.com and moissaniteoutlet.com websites, e-commerce outlets, including marketplaces, drop-ship customers, and other pure-play, exclusively e-commerce customers; and our Traditional segment, which consists of domestic and international distributors and retail customers, including end-consumers through our first Charles & Colvard Signature Showroom, which opened in October 2022. We report segment information based on the “management” approach. This segment reporting approach designates the internal reporting used by management for making operating decisions and assessing performance as the source of our operating and reportable segments.

We operate in an e-commerce environment characterized by both complexity in global markets and ongoing economic uncertainties in the U.S. and internationally. Our strategy is to build a globally revered and accessible brand of gemstones and finished fine jewelry products set with moissanite and lab grown diamonds. We believe that our goods appeal to a wide consumer audience and leverage our advantage of being the original and leading worldwide source of moissanite and purveyor of premium lab grown diamonds. We believe a direct relationship with consumers is an important component to this strategy, which entails delivering tailored educational content, engaging in interactive dialogue with our audience, and positioning our brand to meet the demands of today’s discerning consumer. A significant component of our strategy in this environment is to focus on our core products, improving the quality and predictability of the delivery of our products and services, and placing those products quickly into the hands of our U.S. and international customers at affordable prices. Moreover, recognizing today that our customers and vendors are resource constrained, we are endeavoring to develop and extend our portfolio of products in a disciplined manner with a focus on domestic markets close to our core capabilities, as well as growing our global marketplace sales. We continue to focus on affordability initiatives. We also expect to continue innovating and investing in lab created gemstone technologies to fulfill evolving product requirements for our customers and investing in our people so that we have the technical and production skills necessary to succeed without limiting our ability to build sound financial returns to our investors.

We believe our expanding application of an omni-channel sales strategy across the fine jewelry trade and to the end consumer with accessible gemstones and value branded finished jewelry featuring Charles & Colvard Created Moissanite^® and Caydia^® lab grown diamonds positions our products at the many touchpoints where consumers are when they are making their buying decisions – thereby continuing to create greater exposure for our brand and increasing consumer demand.

21

Fiscal 2023 Financial Outlook

Our strategic goals for the fiscal year ending June 30, 2023, or Fiscal 2023, are centered on continuing to expand Charles & Colvard’s brand on a global scale and to increase the size of our business through top-line growth. As lab-created gemstones are being embraced by emerging generations, we believe our ability to establish moissanite and our lab grown diamonds along with the Charles & Colvard brand directly with conscious consumers is key to our future success and ability to fuel our growth. We plan to continue executing our key Fiscal 2023 strategies with an ongoing commitment to spending judiciously with the long-term plan to generate sustainable earnings.

In January 2023, we launched our bridal and fashion jewelry collections on 15- and 30-second commercial advertisement packages on NBC Universal’s Peacock Streaming Service, or Peacock. Peacock is now the streaming home for NBC’s broadcast shows, including the network’s own Peacock Original Broadcasts on Originals Hub, Bravo Hub, NBC Network Hub, Telemundo Hub, WWE Hub, MSNBC Hub, and Hallmark Channel Hub. In mid-January, we participated in the Wedding Venue at Raleigh, North Carolina’s, Maxwell Winter Showcase. Charles & Colvard was the premier bridal and anniversary jewelry vendor that participated in this event. Raleigh’s Maxwell events are well known in the Central North Carolina region and offer a setting where a touch of modern elegance meets classic luxury. This event, in particular, provided our collections with a premier setting to showcase our bridal and anniversary fine jewelry brands to the regional retail market. Finally, in January, we launched an assortment of our Moissanite by Charles & Colvard^® bridal and fashion jewelry dropship products on Longaberger.com. This marketplace platform is the portal home for products and collectibles known for their artisanal quality and legacy brands. Longaberger.com offers a wide range of home and lifestyle products made in America and abroad that are hand-selected by their team of marketing experts.

In celebration of the February 2023 Valentine’s season, we partnered with Glo de Vie, a local Med Spa located in Raleigh, North Carolina, to host a Valentine’s Day Glow for Love event in our Charles & Colvard Signature Showroom located on our corporate headquarters campus in North Carolina’s Research Triangle Park. This event enabled our marketing team to bring our collections of bridal and fashion jewelry to local consumers in time to contribute to our successful 2023 Valentine’s Day season sales. We also enjoyed successful sale programs for Valentine’s Day on our own online marketplaces – charlesandcolvard.com and moissaniteoutlet.com. Other events during February included our participation as an exhibitor in the NYNOW Winter Show that was held in New York City in early February. We believe that these NYNOW events bring together an exciting kaleidoscope of culture that includes the styles from Manhattan’s uptown sophistication along with its downtown edge. We also believe that these NYNOW events bring together all things stylish – from hip and sleek to artisan-made quality products and are known for presenting the next bestseller items to hit the retail market. Finally, in February we were a proud sponsor for the 2023 Carolina Hurricanes Stadium Series’ Day-to-Day Event Guide, which was published in the February edition of Raleigh Magazine. This event, which took place the weekend of February 17 – 19, 2023, brought Carolina Hurricanes fans and tourists to the Raleigh area. This sponsorship in turn exposed our products to a new set of potential consumers.

In summary, during the quarter, we launched 55 styles of our patented Signature Collection engagement ring and wedding band designs featuring Forever One^™ moissanite and expanded our Caydia^® lab grown diamond Couture Collection to include additional ring, necklace, earring, and bracelet styles. We also expanded our Created Color line of products featuring our Caydia^® lab grown diamond collections. Throughout the fiscal quarter ended March 31, 2023, our finished jewelry products were featured in multiple national and local print and electronic media publications, such as The Knot^®, AC Magazine, Insider.com, Yahoo!, Byrdie.com, and Brides Magazine.

As evidenced by our results for the first nine months of Fiscal 2023, domestic and global inflation and rising interest rates, coupled with ongoing fears of recession and the overall worsening of macro-economic conditions that we witnessed during the quarter ended March 31, 2023, combine to continue eroding consumer confidence and presenting major challenges for the global retail and e-commerce industry. While American consumers continue spending more on consumer goods to keep up with higher prices, consumers are spending on necessities and other required goods and services and moving away from spending on luxury items. We expect that consumers will continue to feel pressured financially, particularly throughout the calendar year 2023. We are facing similar challenges to other retailers, including those in the e-commerce space, but particularly those in the luxury product retail arena. In addition, we continue seeing ongoing increased costs of digital advertising spend, known as cost-per-click in the digital advertising world, due to intense competition and pricing pressures in the lab grown gem and finished jewelry space. While management remains focused to take the required steps necessary to mitigate the impact, the Company’s costs that continue to increase will result in further pressure on its revenues, margins, and cash flows.

22

Inflation

Heightened levels of inflation and the worsening of macro-economic conditions present a risk for us, our suppliers, and the stability of the broader retail and e-commerce industry. During the first nine months of Fiscal 2023, we have experienced impacts to our labor and overhead rates and suppliers have signaled inflation related cost pressures, which have flowed and we expect will continue to flow through to our costs and pricing. While we have seen adverse impact from inflation on our financial results in the first nine months of Fiscal 2023, if inflation remains at current levels for an extended period, or increases further, and we are unable to successfully mitigate the impact, our costs are likely to continue to increase, resulting in further pressure on our revenues, margins, and cash flows. In addition, inflation and the increases in the cost of borrowing from rising interest rates could constrain the overall purchasing power of our customers for our products and services, in particular in the near term to the extent inflation assumptions are less than current inflationary pressures. We remain committed to our ongoing efforts to increase the efficiency of our operations and improve the cost competitiveness and affordability of our products and services, which may, in part, offset cost increases and the adverse effects from inflation.

We discuss our strategic outlook, key strategies, and general economic and market conditions for Fiscal 2023 in Part I, Item 1, “Business” and in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our 2022 Annual Report.

COVID-19

The ultimate impact of COVID-19 on our operations and financial performance in future periods, including management’s ability to execute its strategic initiatives in the expected timeframes, remains uncertain and will depend on future pandemic related developments, including the duration of the pandemic, any potential subsequent waves of COVID-19 and its variant viral infections, the effectiveness, distribution and acceptance of COVID-19 vaccines, and related government actions to prevent and manage disease spread, all of which are uncertain and cannot be predicted. We cannot at this time predict the full impact of the COVID-19 pandemic, but we anticipate that the COVID-19 pandemic will continue to impact our business, financial condition, results of operations, and cash flows in Fiscal 2023.

For additional risks to the Company related to the COVID-19 pandemic, see “Part I, Item 1A. Risk Factors”, contained in our 2022 Annual Report.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which we prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and related disclosures of contingent assets and liabilities. “Critical accounting policies and estimates” are defined as those most important to the financial statement presentation and that require the most difficult, subjective, or complex judgments. We base our estimates on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Under different assumptions and/or conditions, those actual results of operations may materially differ. The most significant estimates impacting our consolidated financial statements relate to the valuation and classification of inventories, accounts receivable reserves, deferred tax assets, stock-based compensation, and revenue recognition. We also have other policies that we consider key accounting policies, but these policies typically do not require us to make estimates or judgments that are difficult or subjective.

We have disclosed our critical accounting policies and estimates in our 2022 Annual Report, and that disclosure should be read in conjunction with this Quarterly Report on Form 10-Q. There have been no significant changes in our critical accounting policies and estimates during the first nine months of Fiscal 2023.

23

Results of Operations

The following table sets forth certain consolidated statements of operations data for the three and nine months ended March 31, 2023 and 2022:

	Three Months Ended March 31,						Nine Months Ended March 31,
	2023			2022			2023			2022
Net sales	$	6,641,799		$	9,751,835		$	24,382,003		$	33,785,281
Costs and expenses:
Cost of goods sold		4,493,125			5,296,530			14,650,910			17,347,026
Sales and marketing		3,267,436			2,932,587			10,715,066			9,741,774
General and administrative		1,053,357			1,106,850			3,654,788			3,880,684
Total costs and expenses		8,813,918			9,335,967			29,020,764			30,969,484
(Loss) Income from operations		(2,172,119	)		415,868			(4,638,761	)		2,815,797
Other income (expense):
Interest income		69,159			1,120			168,935			1,964
Loss on foreign currency exchange		-			-			-			(34	)
Total other income (expense), net		69,159			1,120			168,935			1,930
(Loss) Income before income taxes		(2,102,960	)		416,988			(4,469,826	)		2,817,727
Income tax expense		(6,293,048	)		(78,480	)		(5,858,155	)		(484,582	)
Net (loss) income	$	(8,396,008	)	$	338,508		$	(10,327,981	)	$	2,333,145

Consolidated Net Sales

Consolidated net sales for the three and nine months ended March 31, 2023 and 2022 comprise the following:

	Three Months Ended March 31,				Change						Nine Months Ended March 31,				Change
	2023		2022		Dollars			Percent			2023		2022		Dollars			Percent
Finished jewelry	$	5,321,301	$	7,420,591	$	(2,099,290	)		(28	)%	$	19,297,915	$	23,646,044	$	(4,348,129	)		(18	)%
Loose jewels		1,320,498		2,331,244		(1,010,746	)		(43	)%		5,084,088		10,139,237		(5,055,149	)		(50	)%
Total consolidated net sales	$	6,641,799	$	9,751,835	$	(3,110,036	)		(32	)%	$	24,382,003	$	33,785,281	$	(9,403,278	)		(28	)%

Consolidated net sales were $6.64 million for the three months ended March 31, 2023 compared to $9.75 million for the three months ended March 31, 2022, a decrease of $3.11 million, or 32%. Consolidated net sales were $24.38 million for the nine months ended March 31, 2023 compared to $33.79 million for the nine months ended March 31, 2022, a decrease of $9.40 million, or 28%. We had lower net sales in both operating business segments during the three- and nine-month periods ended March 31, 2023. Overall consumer confidence has continued to show signs of weakening due to general economic uncertainties, coupled with domestic and worldwide inflation, including recessionary fears, and rising interest rates. Notwithstanding the calendar year-end 2022 holiday shopping season and the Valentine’s Day occasion during February 2023, these conditions have brought about lower consumer demand for our finished jewelry products, which resulted in lower net sales in our Online Channels segment during the three and nine months ended March 31, 2023. These same general economic conditions also caused weakness in demand for moissanite jewels from our domestic distributors, which in turn resulted in lower loose jewel and jewelry product net sales during the three- and nine-month periods ended March 31, 2023 in our Traditional segment.

24

Sales of finished jewelry represented 80% and 79% of total consolidated net sales for the three and nine months ended March 31, 2023, respectively, compared to 76% and 70%, respectively, of total consolidated net sales for the corresponding periods of the prior year. For the three months ended March 31, 2023, finished jewelry sales were $5.32 million compared to $7.42 million for the corresponding period of the prior year, a decrease of approximately $2.10 million, or 28%. For the nine months ended March 31, 2023, finished jewelry sales were $19.30 million compared to $23.65 million for the corresponding period of the prior year, a decrease of approximately $4.35 million, or 18%. These decreases in finished jewelry sales for the three- and nine-month periods ended March 31, 2023 were due to lower demand across all of our finished jewelry products as a result of adverse global and domestic general economic conditions.

Sales of loose jewels represented 20% and 21% of total consolidated net sales for the three and nine months ended March 31, 2023, respectively, compared to 24% and 30%, respectively, of total consolidated net sales for the corresponding periods of the prior year. For the three months ended March 31, 2023, loose jewel sales were $1.32 million compared to $2.33 million for the corresponding period of the prior year, a decrease of $1.01 million, or 43%. For the nine months ended March 31, 2023, sales of loose jewels were $5.08 million compared to $10.14 million for the corresponding period of the prior year, a decrease of $5.06 million, or 50%. The decrease in sales of loose jewels for the three- and nine-month periods ended March 31, 2023 was principally due to lower sales of loose jewels through our distribution network in our Online Channels segment and Traditional segment, as a result of global and domestic general adverse macroeconomic conditions.

U.S. net sales accounted for approximately 99% and 97% of total consolidated net sales for the three and nine months ended March 31, 2023, respectively, compared to 96% and 95% of total consolidated net sales for the corresponding periods in the prior year. U.S. net sales decreased $2.85 million, or 30%, during the three months ended March 31, 2023 from the corresponding period of the prior fiscal year. U.S. net sales decreased $8.61 million, or 27%, during the nine months ended March 31, 2023 from the corresponding period of the prior year. U.S. net sales decreased during the three and nine months ended March 31, 2023 primarily as a result of decreased sales to U.S. customers in both our Online Channels segment and Traditional segment for the same reasons outlined above.

Our largest U.S. customer during the three and nine months ended March 31, 2023 accounted for 13% and 14% of total consolidated net sales during each respective period. This same customer was our largest customer during the three and nine months ended March 31, 2022 when this customer accounted for 13% and 15% of total consolidated net sales during each of the respective three- and nine-month periods. Other than our U.S. customer noted above during the three- and nine-month periods ended March 31, 2023 and 2022, we had no other customers with sales that represented 10% or more of total consolidated net sales for the periods then ended. We expect that we, along with our customers, will remain dependent on our ability to maintain and enhance our customer-related programs. A change in or loss of any of these customer or retailer relationships could have a material adverse effect on our results of operations.

International net sales accounted for approximately 1% and 3% of total consolidated net sales for the three and nine months ended March 31, 2023, respectively, compared to 4% and 5% of total consolidated net sales for the corresponding periods of the prior year. International net sales decreased 73% and 51% during the three and nine months ended March 31, 2023, respectively, from the corresponding periods of the prior fiscal year due to lower demand in our international distributor market due to shutdowns in the Asia Pacific region during the nine-month period ended March 31, 2023, coupled with the strength of the U.S. dollar against foreign currencies. In light of the effects of ongoing global economic conditions, we continue to evaluate these and other potential distributors in international markets to determine the best long-term partners. As a result, and in light of the impact from the ongoing worldwide pandemic and international trade challenges, we expect that our sales in these markets may fluctuate significantly each reporting period.

We did not have an international customer account for 10% or more of total consolidated sales during the three and nine months ended March 31, 2023 or 2022. A portion of our international consolidated sales represents jewels sold internationally that may be re-imported to U.S. retailers.

25

Costs and Expenses

Cost of Goods Sold

Cost of goods sold for the three and nine months ended March 31, 2023 and 2022 are as follows:

	Three Months Ended March 31,				Change						Nine Months Ended March 31,				Change
	2023		2022		Dollars			Percent			2023		2022		Dollars			Percent
Product line cost of goods sold:
Finished jewelry	$	2,840,321	$	3,709,864	$	(869,543	)		(23	)%	$	9,632,352	$	10,748,323	$	(1,115,971	)		(10	)%
Loose jewels		645,259		1,013,986		(368,727	)		(36	)%		2,342,133		4,507,997		(2,165,864	)		(48	)%
Total product line cost of goods sold		3,485,580		4,723,850		(1,238,270	)		(26	)%		11,974,485		15,256,320		(3,281,835	)		(22	)%
Non-product line cost of goods sold		1,007,545		572,680		434,865			76	%		2,676,425		2,090,706		585,719			28	%
Total cost of goods sold	$	4,493,125	$	5,296,530	$	(803,405	)		(15	)%	$	14,650,910	$	17,347,026	$	(2,696,116	)		(16	)%

Total cost of goods sold was $4.49 million for the three months ended March 31, 2023 compared to $5.30 million for the three months ended March 31, 2022, a net decrease of approximately $803,000, or 15%. Total cost of goods sold was $14.65 million for the nine months ended March 31, 2023 compared to $17.35 million for the nine months ended March 31, 2022, a net decrease of approximately $2.70 million, or 16%. Product line cost of goods sold is defined as product cost of goods sold in each of our Online Channels segment and Traditional segment excluding non-capitalized expenses from our manufacturing and production control departments, comprising personnel costs, depreciation, rent, utilities, and corporate overhead allocations; freight out; inventory write-downs; and other inventory adjustments, comprising costs of quality issues, and damaged goods.

The decrease in total product line cost of goods sold for the three and nine months ended March 31, 2023 compared to the same period in 2022 was primarily driven by the decreased sales of finished jewelry and loose jewels during the three- and nine-months ended March 31, 2023 in both of our Online Channels segment and Traditional segment. We experienced lower demand in our Online Channels segment as a result of lower finished jewelry product demand during the nine-month period. Likewise, we saw lower loose jewel product demand in our Traditional segment throughout the nine-month period ended March 31, 2023.

The net increase in non-product line cost of goods sold for the three months ended March 31, 2023, comprises a $400,000 increase in other inventory adjustments principally related to changes in production standard cost variances compared to those in the comparable period of the fiscal year ended June 30, 2022, or Fiscal 2022, and an approximate $112,000 increase in non-capitalized manufacturing production control expenses principally related to the timing of when work-in-process goods are received into inventory and overhead costs are allocated. These increases were partially offset by an approximate $77,000 decrease in freight out principally from decreased shipping volume during the three-month period.

The net increase in non-product line cost of goods sold for the nine months ended March 31, 2023, comprises an approximate $417,000 increase in non-capitalized manufacturing production control expenses principally related to the timing of when work-in-process goods are received into inventory and overhead costs are allocated and an approximate $408,000 increase in other inventory adjustments principally related to changes in production standard cost variances compared to those in the first nine months of Fiscal 2022. These increases were partially offset by an approximate $113,000 decrease in inventory write-downs during the first nine months of the Fiscal 2023, compared to those in the comparable prior year period, and an approximate $126,000 decrease in freight out principally from decreased shipping volume during the nine-month period.

For additional disclosure relating to non-product line cost of goods sold, see Note 3 to our condensed consolidated financial statements in Item 1, “Financial Statements”, of this Quarterly Report on Form 10-Q.

26

Sales and Marketing

Sales and marketing expenses for the three and nine months ended March 31, 2023 and 2022 are as follows:

	Three Months Ended March 31,				Change					Nine Months Ended March 31,				Change
	2023		2022		Dollars		Percent			2023		2022		Dollars		Percent
Sales and marketing	$	3,267,436	$	2,932,587	$	334,849		11	%	$	10,715,066	$	9,741,774	$	973,292		10	%

Sales and marketing expenses were $3.27 million for the three months ended March 31, 2023 compared to $2.93 million for the three months ended March 31, 2022, an increase of approximately $335,000, or 11%. Sales and marketing expenses were $10.72 million for the nine months ended March 31, 2023 compared to $9.74 million for the nine months ended March 31, 2022, an increase of approximately $973,000, or 10%.

The net increase in sales and marketing expenses for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to a $274,000 net increase in advertising and digital marketing expenses; a $75,000 increase in general business taxes; a $30,000 increase in compensation expenses; a $9,000 increase in telephone-related communications expenses; a $6,000 increase in professional services principally comprising consulting services for marketing support in the current year period; a $4,000 increase in insurance expense related to increased premiums; and a $1,000 increase in travel expenses. These increases were offset partially by a $53,000 decrease in bank fee expenses, which are principally related to lower credit card transaction and payment platform fees; and an $11,000 decrease in software-related costs incurred primarily in connection with software-related products associated with upgraded sales-related operating systems that were installed in the prior year period.

The increase in advertising and digital marketing expenses for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to a $332,000 increase in digital advertising spend; a $27,000 increase in cooperative advertising in connection with a higher number of cooperative advertising arrangements; a $21,000 increase in outside agency fees; and a $14,000 increase in print media expenses. These increases were offset partially by a $120,000 decrease in brand awareness marketing campaign expenditures as a result of fewer promotional activities in the current year period.

Compensation expenses for the three months ended March 31, 2023 compared to the same period in 2022 increased primarily due to a $126,000 net increase in salaries, commissions, and related employee benefits in the aggregate and a $5,000 increase in severance-related expenses associated with a reduction-in-force during the current year period. These increases were partially offset by a $95,000 decrease in bonus expense and a $6,000 decrease in employee stock-based compensation expense.

The increase in sales and marketing expenses for the nine months ended March 31, 2023 compared to the same period in 2022 was primarily due to a $420,000 increase in advertising and digital marketing expenses; a $196,000 increase in compensation expenses; a $193,000 increase in general business taxes; an $88,000 increase in professional services principally comprising consulting services for marketing support in the current year period; an $18,000 increase in telephone-related communications expenses; a $16,000 increase in software-related costs incurred primarily in connection with new software-related agreements associated with upgraded sales-related operating systems; a $13,000 increase in supplies related to the Signature Showroom during the current year period; a $13,000 increase in bank fees expenses, which are principally related to higher credit card transaction and payment platform fees; a $7,000 increase in employee-related recruiting and search fees for new hires; a $7,000 increase in depreciation and amortization expense principally related to new sales-related systems hardware and software; and a $4,000 net increase in general office-related expenses. These increases were offset partially by a $2,000 decrease in travel expenses.

The increase in advertising and digital marketing expenses for the nine months ended March 31, 2023 compared to the same period in 2022 comprises a $604,000 increase in digital advertising spend and a $61,000 increase in outside agency fees. These increases were offset partially by a $111,000 decrease in expenses relating to our participation in the 2021 JCK Trade Show held in the prior year period for which we did not host a booth in the 2022 JCK Trade show held during the current year period; a $67,000 decrease in cooperative advertising; a $56,000 decrease in brand awareness marketing campaign expenditures as a result of fewer promotional activities in the current year period; and an $11,000 decrease in print media expenses.

Compensation expenses for the nine months ended March 31, 2023 compared to the same period in 2022 increased primarily as a result of a $324,000 increase in salaries, commissions, and related employee benefits in the aggregate and a $5,000 increase in severance-related expenses associated with a reduction-in-force during the current year period. These increases were partially offset by a $106,000 decrease in bonus expense and a $27,000 decrease in employee stock-based compensation expense.

27

General and Administrative

General and administrative expenses for the three and nine months ended March 31, 2023 and 2022 are as follows:

	Three Months Ended March 31,				Change						Nine Months Ended March 31,				Change
	2023		2022		Dollars			Percent			2023		2022		Dollars			Percent
General and administrative	$	1,053,357	$	1,106,850	$	(53,493	)		(5	)%	$	3,654,788	$	3,880,684	$	(225,896	)		(6	)%

General and administrative expenses were $1.05 million for the three months ended March 31, 2023 compared to $1.11 million for the three months ended March 31, 2022, a decrease of approximately $53,000, or 5%. General and administrative expenses were $3.65 million for the nine months ended March 31, 2023 compared to $3.88 million for the nine months ended March 31, 2022, a decrease of approximately $226,000, or 6%.

The net decrease in general and administrative expenses for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to a $147,000 decrease in compensation expenses; an $11,000 decrease in general business taxes and licenses; and an $8,000 decrease in rent expense, primarily related to our corporate headquarters operating lease. These decreases were partially offset by a $62,000 increase in depreciation and amortization expense related to general office leasehold improvements associated with the lease on our corporate headquarters and business expansion related to the opening of our new Charles & Colvard Signature Showroom also located in our headquarters campus; a $20,000 increase in travel and expense-related expenditures as we returned to more traditional business travel patterns; a $15,000 increase in professional services; an $8,000 increase in insurance expense, principally related to increased premiums; and an $8,000 increase in bad debt expense associated with our allowance for doubtful accounts reserve policy.

The decrease in compensation expenses for the three months ended March 31, 2023 compared to the same period in 2022 was primarily due to a $146,000 decrease in employee stock-based compensation expense and a $53,000 decrease in bonus expense. These decreases were partially offset by a $49,000 net increase in salaries and related employee benefits in the aggregate and a $3,000 increase in severance-related expenses associated with a reduction-in-force during the current year period.

Professional services fees increased for the three months ended March 31, 2023 compared to the same period in 2022 primarily due to a $24,000 increase in investor relations fees and a $23,000 increase in legal fees principally associated with the above-referenced reduction-in-force. These increases were partially offset by a $32,000 decrease in fees associated with audit and tax services, principally related to a tax-related consulting project in the prior year period.

The net decrease in general and administrative expenses for the nine months ended March 31, 2023 compared to the nine-month period ended March 31, 2022 was primarily due to a $396,000 decrease in compensation expenses; a $146,000 decrease in bank fees resulting from the revised fee structure associated with different banking arrangements in place in the current period versus those in the year ago period; a $44,000 decrease in bad debt expense associated with our allowance for doubtful accounts reserve policy; and a $5,000 decrease in rent expense, primarily related to our corporate headquarters operating lease. These decreases were partially offset by a $131,000 increase in depreciation and amortization expense related to general office leasehold improvements associated with the lease on our corporate headquarters and business expansion related to the opening of our new Charles & Colvard Signature Showroom also located in our headquarters campus; a $97,000 increase in general business taxes and licenses; an $83,000 increase in travel and expense related expenditures as we returned to more traditional business travel patterns; a $30,000 increase in professional services; a $23,000 increase in insurance expense, principally related to increased premiums; and a $1,000 net increase in miscellaneous other general and administrative expenses.

Compensation expenses decreased for the nine months ended March 31, 2023 compared to the same period in 2022 principally due to a $420,000 decrease in employee stock-based compensation expense and a $222,000 decrease in bonus expense. These decreases were partially offset by a $242,000 net increase in salaries and related employee benefits in the aggregate and a $4,000 increase in severance-related expenses associated with a reduction-in-force during the current year period.

Professional services fees increased for the nine months ended March 31, 2023 compared to the nine-month period ended March 31, 2022 primarily due to a $38,000 increase in broker commissions primarily related to our stock repurchase program and a $5,000 increase in legal fees associated with corporate governance matters. These increases were partially offset by a $13,000 decrease in fees associated with audit and tax services, principally related to a tax-related consulting project in the prior year period.

28

Interest Income

Interest income for the three and nine months ended March 31, 2023 and 2022 is as follows:

	Three Months Ended March 31,				Change					Nine Months Ended March 31,				Change
	2023		2022		Dollars		Percent			2023		2022		Dollars		Percent
Interest income	$	69,159	$	1,120	$	68,039		*	%	$	168,935	$	1,964	$	166,971		*	%

* Not meaningful

Certain cash balances in excess of operating needs are deposited into and maintained in an interest-bearing account with a commercial bank. Accordingly, during the three- and nine-month periods ended March 31, 2023 and 2022, we earned interest from cash on deposit in this interest-bearing account. The increase in earned interest for the three and nine months ended March 31, 2023 reflects movement of invested funds into a higher-yield money market fund in late Fiscal 2022, coupled with the overall increase in interest rates during the first nine months of Fiscal 2023 compared with the same period in Fiscal 2022.

Loss on Foreign Currency Exchange

Losses on foreign currency exchange related to foreign sales transacted in functional currencies other than the U.S. dollar for the three and nine months ended March 31, 2023 and 2022 are as follows:

	Three Months Ended March 31,				Change					Nine Months Ended March 31,				Change
	2023		2022		Dollars		Percent			2023		2022		Dollars			Percent
Loss on foreign currency exchange	$	-	$	-	$	-		-	%	$	-	$	34	$	(34	)		(100	)%

During the nine months ended March 31, 2022, we had international sales transactions denominated in currencies other than the U.S. dollar that resulted in foreign currency exchange net losses. There were no such international sales transactions denominated in foreign currencies during the nine-month period ended March 31, 2023.

Provision for Income Taxes

As of each reporting date, we consider new evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets. During the three months ended March 31, 2023, we determined that due to the worsening global macro-economic conditions and heightened levels of inflation, including fears of recession, coupled with the effects from worldwide political unrest and the ongoing economic impact from the COVID pandemic, the risks associated with these conditions led management to conclude that it was not more likely than not we would have sufficient future taxable income to utilize our deferred tax assets. Additionally, we determined that the positive evidence was no longer sufficient to offset available negative evidence, primarily as a result of the pre-tax operating losses incurred during the nine-month period ended March 31, 2023. Consequently, we established a full valuation allowance against the deferred tax assets, resulting in an income tax expense of approximately $6.29 million and $5.86 million for the three and nine months ended March 31, 2023, respectively. We recognized an income tax expense of approximately $78,000 and $485,000 for the three and nine months ended March 31, 2022, respectively.

Our effective income tax rate reflects the effect of federal and state income taxes on earnings and the impact of differences in book and tax accounting arising primarily from the permanent tax benefits associated with stock-based compensation transactions during the quarter. Driven by the establishment of the valuation allowance during the quarter ended March 31, 2023, our effective tax rate for the nine month-period then ended was a negative 131.06%. For the nine months ended March 31, 2022, our effective tax rate was 17.20%.

29

Liquidity and Capital Resources

Our business depends on consumer demand for our products and could be adversely impacted by unfavorable general economic conditions, declines in consumer confidence and consumer disposable income, rising energy and fuel prices, increasing freight costs, rising inflation rates, recession and fears of recession, consumer debt levels, increased interest rates, and higher tax rates. The full effect of these factors on the global and domestic economy remains uncertain. In addition, the full impact of the ongoing COVID-19 pandemic on our business remains uncertain as well at this time. Accordingly, we remain increasingly focused on the general macroeconomic conditions outlined herein as well as on the COVID-19 pandemic. We are continually evaluating their potential effect on our business and liquidity and capital resources.

Capital Structure and Long-Term Debt

Short-Term Liquidity and Capital Structure

The Consolidated Appropriations Act, 2021, provides that employers who received a Paycheck Protection Program, or PPP, loan may also qualify for the Employee Retention Credit, or ERC. Previously, pursuant to the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, taxpayers that received a PPP loan were not eligible for the ERC and this change is retroactive to March 27, 2020. We believe that we may qualify for certain employer-related tax benefits pursuant to the ERC and are currently working with an independent third-party tax credit firm to amend our applicable federal payroll tax returns for such benefit. Any benefit received in connection with available ERC credits will be recognized in the period such credits are received.

Long-Term Liquidity and Capital Structure

We have an effective shelf registration statement on Form S-3 on file with the SEC that allows us to periodically offer and sell, individually or in any combination, shares of common stock, shares of preferred stock, warrants to purchase shares of common stock or preferred stock, and units consisting of any combination of the foregoing types of securities, up to a total of $25.00 million, of which all is available. However, we may offer and sell no more than one-third of our public float (which is the aggregate market value of our outstanding common stock held by non-affiliates) in any 12-month period. Our ability to issue equity securities under the shelf registration statement is subject to market conditions, which may be in turn, subject to, among other things, the potential disruption and volatility that may be caused by ongoing macroeconomic effects of the COVID-19 pandemic.  Accordingly, any capital raise is not assured and these conditions may adversely affect our ability to raise capital under the shelf registration statement, if at all.

As previously disclosed, on December 19, 2022, we received notice from Nasdaq’s Listing Qualifications Department indicating that we were not in compliance with Nasdaq’s listing requirements because the minimum bid price of our common stock on The Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days. In accordance with the Nasdaq’s listing requirements, we had 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement.

On April 20, 2023, we received a letter from the Nasdaq Listing Qualifications Department notifying us that the minimum bid price of our common stock was $1.00 per share or greater for at least the last 10 consecutive business days. Accordingly, we have regained compliance with the Nasdaq minimum bid price requirement and the matter is now closed.

Debt

We have no short- or long-term outstanding debt as of March 31, 2023.

Financing Activities

Long-Term Financing Activities

In accordance with authority granted by our Board of Directors on April 29, 2022, we can repurchase up to $5.00 million in shares outstanding of our common stock over the three-year period ending April 29, 2025. Pursuant to the terms of the repurchase authorization, the common stock share repurchases are generally at the discretion of management. As we repurchase our common shares, which have no par value, we report such shares held as treasury stock on our condensed consolidated balance sheets, with the purchase price recorded within treasury stock.

During the nine-month period ended March 31, 2023, we repurchased 358,116 shares of our common stock for an aggregate price of $451,815 pursuant to the repurchase authorization. We repurchased no shares of our common stock during the three-month period ended March 31, 2023.

30

Operating Activities and Cash Flows

We require cash to fund our operating expenses and working capital requirements, including outlays for capital expenditures. As of March 31, 2023, our principal sources of liquidity were cash and cash equivalents of $10.91 million, trade accounts receivable of $934,000, and net current inventory of $7.89 million, as compared to cash and cash equivalents of $15.67 million, trade accounts receivable of $2.22 million, and net current inventory of $11.02 million as of June 30, 2022. We also had access during the nine-month period ended March 31, 2023 to a $5.00 million cash collateralized line of credit facility, or the JPMorgan Chase Credit Facility, that we obtained effective July 9, 2021, as amended July 28, 2022, from JPMorgan Chase Bank, N.A., or JPMorgan Chase.

During the nine months ended March 31, 2023, our working capital decreased by approximately $8.52 million to $20.54 million from $29.06 million at June 30, 2022. As described more fully below, the decrease in working capital at March 31, 2023 is primarily attributable to a net decrease in our cash, cash equivalents, and restricted cash, a decrease in our allocation of inventory from long-term to short-term due to a lower expected sell through of inventory on hand in the upcoming period, a decrease in our accounts receivable, a decrease in our prepaid expenses and other assets, the classification of the note receivable as noncurrent as of March 31, 2023 as compared to current as of June 30, 2022, and an increase in our short-term operating lease liabilities. These factors were offset partially by a decrease in our accounts payable and a decrease in our accrued expenses and other liabilities. Our cash used for investing activities were principally for construction-in-process expenditures related to our retail expansion program and the construction of our first Charles & Colvard Signature Showroom and other leasehold improvements in the corporate offices at our headquarters campus. Our cash used for financing activities was principally for our share repurchase program.

During the nine months ended March 31, 2023, approximately $3.83 million of cash was used by our operations. The primary drivers of our use of cash were a net loss in the amount of approximately $10.33 million; a decrease in accounts payable of $1.28 million; and a decrease in accrued expenses and other liabilities of $981,000. These factors were offset partially by the favorable impact of approximately $6.58 million of non-cash expenses driven by the deferred tax valuation allowance recorded during the quarter ended March 31, 2023, a decrease in accounts receivable of $1.25 million; a decrease in prepaid expenses and other assets of $757,000; and a decrease in inventory of $181,000.

Accounts receivable decreased principally due to the decreased level of sales on credit during the three months ended March 31, 2023, as compared with the sales during the period leading up to June 30, 2022. From time to time, we have offered extended Traditional segment customer payment terms beyond 90 days to certain credit-worthy customers. Because of the ongoing impact of the pandemic on the global economy, the extension of these terms may not immediately increase liquidity as a result of ongoing current-period sales, which we expect may continue to be pressured due to the effects of the ongoing pandemic. In addition, we believe our competitors and other vendors in the wholesale jewelry industry have expanded their use of extended payment terms and, in aggregate, we believe that, through our use of extended payment terms, we provide a competitive response in our market during the current global economic environment. We believe that we are unable to estimate the impact of these actions on our net sales, but we believe that if we ceased providing extended payment terms, we would be at a competitive disadvantage for some Traditional segment customers in the marketplace during this economic period and that our net sales and profits would likely be adversely impacted.

We manufactured approximately $10.57 million in finished jewelry and $5.88 million in loose jewels, which includes the cost of the loose jewels and the purchase of precious metals and labor in connection with jewelry production, during the nine months ended March 31, 2023. We expect our purchases of precious metals and labor to increase as we increase our finished jewelry business. In addition, the price of gold has fluctuated significantly over the past decade, resulting in higher retail price points for gold jewelry. Because the market prices of gold and other precious metals are beyond our control, upward price trends could have a negative impact on our operating cash flow as we manufacture finished jewelry.

Historically, our raw material inventories of SiC crystals had been purchased under exclusive supply agreements with a limited number of suppliers. Because the supply agreements restricted the sale of these crystals exclusively to us, the suppliers negotiated minimum purchase commitments with us that, when combined with reduced sales levels during prior periods in which the purchase commitments were in effect, have resulted in levels of inventories that are higher than we might otherwise maintain. As of March 31, 2023 and June 30, 2022, $25.44 million and $22.49 million of our inventories were classified as long-term assets. Loose jewel sales and finished jewelry that we manufacture will utilize both the finished goods loose jewels currently on-hand and, as we deplete certain shapes and sizes, our on-hand raw material SiC crystals of $812,000 and new raw material that we purchase pursuant to the Supply Agreement.

With our investment in the lab grown diamond product line in recent periods, the level of our lab grown diamond inventory, which has a higher carrying value, has increased to support the business and expected product sales. This has contributed to the growth in our overall inventory levels compared with prior periods.

31

Our more detailed description of our inventories is included in Note 5 to our condensed consolidated financial statements in Part I, Item 1, “Financial Statements”, of this Quarterly Report on Form 10-Q.

As of March 31, 2023, all of our remaining federal income tax credits had expired or been utilized, and therefore, are not available to be carried forward to offset future income taxes. As of March 31, 2023, we also had a federal tax net operating loss carryforward of approximately $16.53 million expiring between 2034 and 2038, or that have no expiration, which can be used to offset against future federal taxable income; North Carolina tax net operating loss carryforwards of approximately $19.87 million expiring between 2023 and 2035; and various other state tax net operating loss carryforwards expiring between 2023 and 2040, which can be used to offset against future state taxable income.

Short-Term Capital Resources

Line of Credit

Effective July 7, 2021, we obtained from JPMorgan Chase our $5.00 million cash collateralized JPMorgan Chase Credit Facility. The JPMorgan Chase Credit Facility may be used for general corporate and working capital purposes, including permitted acquisitions and certain additional indebtedness for borrowed money, installment obligations, and obligations under capital and operating leases. The JPMorgan Chase Credit Facility is secured by a cash deposit in the amount of $5.05 million held by JPMorgan Chase as collateral for the line of credit facility. Effective July 28, 2022, the JPMorgan Chase Credit Facility was amended to, among other things, extend the maturity date to July 31, 2023, and append our obligations under the JPMorgan Chase Credit Facility to be guaranteed by our wholly owned subsidiaries, Charles & Colvard Direct, LLC, charlesandcolvard.com, LLC, and moissaniteoutlet.com, LLC.

Each advance under the JPMorgan Chase Credit Facility, as amended, accrues interest at a rate equal to the sum of JPMorgan Chase’s monthly secured overnight financing rate, or the SOFR rate, to which JPMorgan Chase is subject with respect to the adjusted SOFR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum and an unsecured to secured interest rate adjustment of 0.10% per annum. Prior to its amendment, each advance under the JPMorgan Chase Credit Facility would have accrued interest at a rate equal to JPMorgan Chase’s monthly LIBOR rate multiplied by a statutory reserve rate for eurocurrency funding to which JPMorgan Chase is subject with respect to the adjusted LIBOR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum. Interest is calculated monthly on an actual/360-day basis and payable monthly in arrears. Principal outstanding during an event of default, at JPMorgan Chase’s option, accrues interest at a rate of 3% per annum in excess of the above rate. Any advance may be prepaid in whole or in part at any time.

As of March 31, 2023, we had not borrowed against the JPMorgan Chase Credit Facility.

Long-Term Contractual Commitment

Contractual Agreement

On December 12, 2014, we entered into the Supply Agreement with Cree, Inc., now known as Wolfspeed, Inc., or Wolfspeed. Under the Supply Agreement, subject to certain terms and conditions, we agreed to exclusively purchase from Wolfspeed, and Wolfspeed agreed to exclusively supply, 100% of our required SiC materials in quarterly installments that must equal or exceed a set minimum order quantity. The initial term of the Supply Agreement was scheduled to expire on June 24, 2018, unless extended by the parties. Effective June 22, 2018, the Supply Agreement was amended to extend the expiration date to June 25, 2023. The Supply Agreement, as amended, also provides for the exclusive production of the raw materials used in our premium moissanite product, Forever One™ and provided us with one option, subject to certain conditions, to unilaterally extend the term of the Supply Agreement for an additional two-year period following the expiration of the initial term. In addition, the amendment to the Supply Agreement established a process by which Wolfspeed may begin producing alternate SiC material based on our specifications that will give us the flexibility to use the materials in a broader variety of our products, as well as to permit us to purchase certain amounts of SiC materials from third parties under limited conditions. On August 26, 2020, the Supply Agreement was further amended, effective June 30, 2020, to extend the expiration date to June 29, 2025, which may be further extended by mutual agreement of the parties. The Supply Agreement was also amended to, among other things, (i) spread our total purchase commitment under the Supply Agreement in the amount of approximately $52.95 million over the term of the Supply Agreement, as amended; (ii) establish a process by which Wolfspeed has agreed to accept purchase orders in excess of the agreed-upon minimum purchase commitment, subject to certain conditions; and (iii) permit us to purchase revised amounts of SiC materials from third parties under limited conditions. Our total purchase commitment under the Supply Agreement, as amended, until June 2025 is approximately $52.95 million, of which approximately $24.75 million remains to be purchased as of March 31, 2023.

During the nine months ended March 31, 2023 and 2022, we purchased approximately $1.80 million and $4.49 million, respectively, of SiC crystals from Wolfspeed pursuant to the terms of the Supply Agreement, as amended. We have made no purchases of SiC crystals from Wolfspeed during the six-month period ended March 31, 2023 while currently in discussions regarding the purchase commitment terms of the Supply Agreement. Going forward, we expect to use existing cash and cash equivalents and access to other working capital resources, including but not limited to the potential issuance of equity securities, together with future cash expected to be provided by our operating activities to make purchases in accordance with the terms of the Supply Agreement, as amended.

32

Liquidity and Capital Trends

We believe that our existing cash and cash equivalents and cash expected to be provided by operating activities combined will be sufficient to meet our working capital and capital expenditure needs over the next twelve months.

From a long-term perspective, we believe that our ongoing access to capital markets, including but not limited to the issuance of equity securities or even potential debt securities, coupled with cash provided by operating activities in future periods beyond the next twelve months, will continue to provide us with the necessary liquidity to meet our long-term working capital and capital expenditure requirements.

In connection with our short- and long-term capital resources, we have an effective shelf registration statement on Form S-3 on file with the SEC that allows us to periodically offer and sell, individually or in any combination, shares of common stock, shares of preferred stock, warrants to purchase shares of common stock or preferred stock, and units consisting of any combination of the foregoing types of securities, up to a total of $25.00 million, of which all is available. However, we may offer and sell no more than one-third of our public float (which is the aggregate market value of our outstanding common stock held by non-affiliates) in any 12-month period. As outlined above under the caption, Long-Term Liquidity and Capital Structure, our ability to issue equity securities under the shelf registration statement is subject to market conditions, which may be in turn, subject to, among other things, the potential disruption and volatility that may be caused by ongoing macroeconomic effects of the COVID-19 pandemic. Accordingly, any capital raise is not assured and these conditions may adversely affect our ability to raise capital under the shelf registration statement, if at all.

Our future capital requirements and the adequacy of available funds will depend on many factors, including the ongoing uncertainty surrounding COVID-19 that could lead to further disruption and volatility in the global capital markets as well as its impact on our rate of sales growth; the expansion of our sales and marketing activities; the timing and extent of raw materials and labor purchases in connection with loose jewel production to support our moissanite jewels and lab grown diamond business and precious metals and labor purchases in connection with jewelry production to support our finished jewelry business; the timing of capital expenditures; and the risk factors described in more detail in “Risk Factors” in Part II, Item 1A, of this Quarterly Report on Form 10-Q and in Part I, Item 1A, of our 2022 Annual Report on Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

We routinely review our internal control over financial reporting and from time to time make changes intended to enhance the effectiveness of our internal control over financial reporting. We will continue to evaluate the effectiveness of our disclosure controls and procedures and internal control over financial reporting on an ongoing basis and will take action as appropriate. During the three months ended March 31, 2023, we made no changes to our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, that we believe materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

There are no material pending legal proceedings to which we are a party or to which any of our property is subject.

Item 1A. Risk Factors

We discuss in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2022 and December 31, 2022 various risks that may materially affect our business. There have been no material changes to such risks, except as set forth below.

The effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain. We could be negatively impacted by the widespread outbreak of an illness or other communicable disease, or any other public health crisis that results in economic and trade disruptions. During Fiscal 2023, our performance has been affected by supply chain disruptions and delays, as well as labor challenges associated with employee absences, travel restrictions, quarantine restrictions, remote work, and adjusted work schedules. The impact of COVID-19 on our operational and financial performance in future periods, including our ability to execute our business plans in the expected timeframe, remains uncertain and will depend on future COVID-19-related developments, including the impact of COVID-19 infection or potential new variants or subvariants, the effectiveness and adoption of COVID-19 vaccines and therapeutics, supplier impacts and related government actions to prevent and manage disease spread, including the implementation of any federal, state, local or foreign COVID-19-related controls. The long-term impacts of COVID-19 on consumer shopping and spending patterns, including product and commodity priorities affected by general economic conditions that impact demand for our products and services and our business also are difficult to predict, but could negatively affect our future results and performance.

Our failure to maintain compliance with Nasdaq’s continued listing requirements could result in the delisting of our common stock. Our common stock is currently listed on The Nasdaq Capital Market. In order to maintain this listing, we must satisfy minimum financial and other requirements. On three separate occasions in the past five years, including on one occasion in Fiscal 2023, we have received notification letters from Nasdaq indicating that we were not in compliance with listing requirements because the minimum bid price of our common stock closed below $1.00 per share for 30 consecutive business days. However, Nasdaq subsequently notified us that we had regained compliance with the minimum bid price requirement. If we fail to satisfy all applicable Nasdaq listing requirements in the future, we may take actions to regain compliance, but we can provide no assurance that any such action would prevent our common stock from dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq’s listing requirements. If we fail to continue to meet all applicable listing requirements in the future and Nasdaq determines to delist our common stock, the delisting could substantially decrease trading in our common stock and adversely affect the market liquidity of our common stock; adversely affect our ability to obtain financing on acceptable terms, if at all, and may result in the potential loss of confidence by investors, suppliers, customers, employees, and fewer business development opportunities. Additionally, the market price of our common stock may decline further and shareholders may lose some or all of their investment.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Period	Total Number of Shares Purchased		Average Price Paid per share		Total Number of shares Purchased as Part of Publicly Announced Plans or Programs(1)		Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
January 1, 2023 – January 31, 2023		-	$	-		-	$	4,510,021
February 1, 2023 – February 28, 2023		-	$	-		-	$	4,510,021
March 1, 2023 – March 31, 2023		-	$	-		-	$	4,510,021
Total		-	$	-		-	$	4,510,021

⁽¹⁾ On May 5, 2022, we announced that our Board of Directors had approved a share repurchase program to permit us to repurchase up to $5.00 million worth of our issued and outstanding common stock over the three-year period ending April 29, 2025.

34

Item 6. Exhibits

The following exhibits are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K:

Exhibit No.	Description
31.1	Certification by Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification by Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase document
104	Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CHARLES & COLVARD, LTD.
	By:	/s/ Don O’Connell
May 4, 2023		Don O’Connell
		President and Chief Executive Officer
	By:	/s/ Clint J. Pete
May 4, 2023		Clint J. Pete
		Chief Financial Officer
		(Principal Financial Officer and Chief Accounting Officer)

36

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECURITIES AND EXCHANGE ACT OF 1934

RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Don O’Connell, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 of Charles & Colvard, Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ Don O’Connell
May 4, 2023		Don O’Connell
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECURITIES AND EXCHANGE ACT OF 1934

RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Clint J. Pete, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023 of Charles & Colvard, Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ Clint J. Pete
May 4, 2023		Clint J. Pete
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Don O’Connell, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Don O’Connell
	Don O’Connell
	President and Chief Executive Officer
	May 4, 2023

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Clint J. Pete, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Clint J. Pete
	Clint J. Pete
	Chief Financial Officer
	May 4, 2023

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	000-23329
Entity Registrant Name	Charles & Colvard, Ltd.
Entity Central Index Key	0001015155
Entity Incorporation, State or Country Code	NC
Entity Tax Identification Number	56-1928817
Entity Address, Address Line One	170 Southport Drive
Entity Address, City or Town	Morrisville
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27560
City Area Code	919
Local Phone Number	468-0399
Title of 12(b) Security	Common Stock, no par value per share
Trading Symbol	CTHR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		30,523,705

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Current assets:
Cash and cash equivalents	$ 10,914,584	$ 15,668,361
Restricted cash	5,056,044	5,510,979
Accounts receivable, net	933,553	2,220,816
Inventory, net	7,889,917	11,024,276
Note receivable	0	250,000
Prepaid expenses and other assets	883,814	1,190,012
Total current assets	25,677,912	35,864,444
Long-term assets:
Inventory, net	25,439,369	22,488,524
Property and equipment, net	2,317,738	1,901,176
Intangible assets, net	301,310	265,730
Operating lease right-of-use assets	2,336,334	2,787,419
Deferred income taxes, net	0	5,851,904
Note receivable	250,000	0
Other assets	50,387	49,658
Total long-term assets	30,695,138	33,344,411
TOTAL ASSETS	56,373,050	69,208,855
Current liabilities:
Accounts payable	3,116,810	4,401,229
Operating lease liabilities, current portion	874,177	856,571
Accrued expenses and other liabilities	1,143,192	1,546,483
Total current liabilities	5,134,179	6,804,283
Long-term liabilities:
Noncurrent operating lease liabilities	2,251,581	2,846,805
Total long-term liabilities	2,251,581	2,846,805
Total liabilities	7,385,760	9,651,088
Commitments and contingencies (Note 9)
Shareholders' equity:
Common stock, no par value; 50,000,000 shares authorized; 30,912,108 shares issued and 30,523,705 shares outstanding at March 31, 2023 and 30,778,046 shares issued and 30,747,759 shares outstanding at June 30, 2022	57,242,211	57,242,211
Additional paid-in capital	26,165,810	25,956,491
Treasury stock, at cost, 388,403 shares and 30,287 shares at March 31, 2023 and June 30, 2022, respectively	(489,979)	(38,164)
Accumulated deficit	(33,930,752)	(23,602,771)
Total shareholders' equity	48,987,290	59,557,767
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 56,373,050	$ 69,208,855

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2023	Jun. 30, 2022
Shareholders' equity
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	30,912,108	30,778,046
Common stock, shares outstanding (in shares)	30,523,705	30,747,759
Treasury stock (in shares)	388,403	30,287

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 6,641,799	$ 9,751,835	$ 24,382,003	$ 33,785,281
Costs and expenses:
Cost of goods sold	4,493,125	5,296,530	14,650,910	17,347,026
Sales and marketing	3,267,436	2,932,587	10,715,066	9,741,774
General and administrative	1,053,357	1,106,850	3,654,788	3,880,684
Total costs and expenses	8,813,918	9,335,967	29,020,764	30,969,484
(Loss) Income from operations	(2,172,119)	415,868	(4,638,761)	2,815,797
Other income (expense):
Interest income	69,159	1,120	168,935	1,964
Loss on foreign currency exchange	0	0	0	(34)
Total other income (expense), net	69,159	1,120	168,935	1,930
(Loss) Income before income taxes	(2,102,960)	416,988	(4,469,826)	2,817,727
Income tax expense	(6,293,048)	(78,480)	(5,858,155)	(484,582)
Net (loss) income	$ (8,396,008)	$ 338,508	$ (10,327,981)	$ 2,333,145
Net (loss) income per common share:
Basic (in dollars per share)	$ (0.28)	$ 0.01	$ (0.34)	$ 0.08
Diluted (in dollars per share)	$ (0.28)	$ 0.01	$ (0.34)	$ 0.07
Weighted average number of shares used in computing net (loss) income per common share:
Basic (in shares)	30,344,954	30,484,897	30,387,303	30,286,195
Diluted (in shares)	30,344,954	31,268,410	30,387,303	31,271,677

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]	Total
Balance at Jun. 30, 2021	$ 56,057,109	$ 25,608,593	$ 0	$ (25,976,686)	$ 55,689,016
Balance (in shares) at Jun. 30, 2021					29,913,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	279,407	0	0	$ 279,407
Issuance of restricted stock	$ 0	0	0	0	0
Issuance of restricted stock (in shares)	242,725
Stock option exercises	$ 397,112	(139,742)	0	0	257,370
Stock option exercises (in shares)	183,637
Net (loss) income	$ 0	0	0	827,025	827,025
Balance at Sep. 30, 2021	56,454,221	25,748,258	0	(25,149,661)	$ 57,052,818
Balance (in shares) at Sep. 30, 2021					30,339,457
Balance at Jun. 30, 2021	56,057,109	25,608,593	0	(25,976,686)	$ 55,689,016
Balance (in shares) at Jun. 30, 2021					29,913,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income					$ 2,333,145
Balance at Mar. 31, 2022	57,066,143	25,927,410	0	(23,643,541)	$ 59,350,012
Balance (in shares) at Mar. 31, 2022					30,688,796
Balance at Sep. 30, 2021	56,454,221	25,748,258	0	(25,149,661)	$ 57,052,818
Balance (in shares) at Sep. 30, 2021					30,339,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	199,004	0	0	$ 199,004
Stock option exercises	$ 447,877	(159,329)	0	0	288,548
Stock option exercises (in shares)	255,590
Net (loss) income	$ 0	0	0	1,167,612	1,167,612
Balance at Dec. 31, 2021	56,902,098	25,787,933	0	(23,982,049)	$ 58,707,982
Balance (in shares) at Dec. 31, 2021					30,595,047
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	198,523	0	0	$ 198,523
Stock option exercises	$ 164,045	(59,046)	0	0	104,999
Stock option exercises (in shares)	93,749
Net (loss) income	$ 0	0	0	338,508	338,508
Balance at Mar. 31, 2022	57,066,143	25,927,410	0	(23,643,541)	$ 59,350,012
Balance (in shares) at Mar. 31, 2022					30,688,796
Balance at Jun. 30, 2022	57,242,211	25,956,491	(38,164)	(23,602,771)	$ 59,557,767
Balance (in shares) at Jun. 30, 2022					30,747,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	96,232	0	0	$ 96,232
Cancellation of restricted stock	$ 0	0	0	0	0
Cancellation of restricted stock (in shares)	(44,688)
Repurchases of common stock	$ 0	0	$ (451,815)	0	(451,815)
Repurchases of common stock (in shares)			(358,116)
Net (loss) income	0	0	$ 0	(890,192)	(890,192)
Balance at Sep. 30, 2022	57,242,211	26,052,723	(489,979)	(24,492,963)	$ 58,311,992
Balance (in shares) at Sep. 30, 2022					30,344,955
Balance at Jun. 30, 2022	57,242,211	25,956,491	(38,164)	(23,602,771)	$ 59,557,767
Balance (in shares) at Jun. 30, 2022					30,747,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock					$ (451,815)
Repurchases of common stock (in shares)					(358,116)
Net (loss) income					$ (10,327,981)
Balance at Mar. 31, 2023	57,242,211	26,165,810	(489,979)	(33,930,752)	$ 48,987,290
Balance (in shares) at Mar. 31, 2023					30,523,705
Balance at Sep. 30, 2022	57,242,211	26,052,723	(489,979)	(24,492,963)	$ 58,311,992
Balance (in shares) at Sep. 30, 2022					30,344,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	78,493	0	0	$ 78,493
Issuance of restricted stock	$ 0	0		0	0
Issuance of restricted stock (in shares)	178,750
Net (loss) income	$ 0	0	0	(1,041,781)	(1,041,781)
Balance at Dec. 31, 2022	57,242,211	26,131,216	(489,979)	(25,534,744)	$ 57,348,704
Balance (in shares) at Dec. 31, 2022					30,523,705
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	0	34,594	0	0	$ 34,594
Repurchases of common stock (in shares)					0
Net (loss) income	0	0	0	(8,396,008)	$ (8,396,008)
Balance at Mar. 31, 2023	$ 57,242,211	$ 26,165,810	$ (489,979)	$ (33,930,752)	$ 48,987,290
Balance (in shares) at Mar. 31, 2023					30,523,705

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (10,327,981)	$ 2,333,145
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	477,285	350,198
Stock-based compensation	209,319	676,934
(Recovery of) Provision for uncollectible accounts	(18,000)	26,000
Provision for (Recovery of) sales returns	59,000	(25,000)
Inventory write-downs	119,000	232,000
Provision for accounts receivable discounts	42	3,269
Deferred income taxes	5,851,904	483,168
Changes in operating assets and liabilities:
Accounts receivable	1,246,221	92,264
Inventory	64,514	(3,562,704)
Prepaid expenses and other assets, net	756,554	640,843
Accounts payable	(1,284,419)	356,311
Accrued income taxes	0	1,414
Accrued expenses and other liabilities	(980,909)	(504,862)
Net cash (used in) provided by operating activities	(3,827,470)	1,102,980
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(884,030)	(1,250,296)
Payments for intangible assets	(45,397)	(38,867)
Net cash used in investing activities	(929,427)	(1,289,163)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchases of common stock	(451,815)	0
Stock option exercises	0	650,917
Net cash (used in) provided by financing activities	(451,815)	650,917
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(5,208,712)	464,734
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD	21,179,340	21,446,951
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD	15,970,628	21,911,685
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	$ 5,900	$ 0

XML

DESCRIPTION OF BUSINESS

9 Months Ended

Mar. 31, 2023

DESCRIPTION OF BUSINESS [Abstract]

DESCRIPTION OF BUSINESS

1. DESCRIPTION OF BUSINESS

Charles & Colvard, Ltd. (the “Company”), a North Carolina corporation, was founded in 1995. The Company manufactures, markets, and distributes Charles & Colvard Created Moissanite^® (hereinafter referred to as moissanite or moissanite jewels) and finished jewelry featuring moissanite, including Forever One™, the Company’s premium moissanite gemstone brand, for sale in the worldwide fine jewelry market. The Company also markets and distributes Caydia^® lab grown diamonds and finished jewelry featuring lab grown diamonds for sale in the worldwide fine jewelry market. Moissanite, also known by its chemical name silicon carbide (“SiC”), is a rare mineral first discovered in a meteorite crater. Because naturally occurring SiC crystals are too small for commercial use, larger crystals must be grown in a laboratory. Lab grown diamonds are also grown using technology that replicates the natural diamond growing process. The only differentiation between that of a lab grown diamond and a mined diamond is its origin. The result is a man-made diamond that is chemically, physically, and optically the same as those grown beneath the earth’s surface.

The Company sells loose moissanite jewels, loose lab grown diamonds, and finished jewelry featuring both moissanite and lab grown diamonds at wholesale prices to distributors, manufacturers, retailers, and designers, including some of the largest distributors and jewelry manufacturers in the world. The Company’s finished jewelry and loose moissanite jewels and lab grown diamonds that are mounted into fine jewelry by other manufacturers are sold at retail outlets and via the Internet. The Company sells at retail prices to end-consumers through its own Charles & Colvard Signature Showroom, which opened in October 2022, and also through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, third-party online marketplaces, drop-ship, and other pure-play, exclusively e-commerce outlets. The Company also sells at discount retail prices to end-consumers through moissaniteoutlet.com, LLC, a wholly owned operating subsidiary of charlesandcolvard.com, LLC, and third-party online marketplaces.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Mar. 31, 2023

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation – The accompanying unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. However, certain information or footnote disclosures normally included in complete financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q include all normal and recurring adjustments necessary for the fair statement of the results for the interim periods presented. The results for the nine months ended March 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2023 (“Fiscal 2023”).

The condensed consolidated financial statements as of March 31, 2023 and for the three and nine months ended March 31, 2023 and 2022 included in this Quarterly Report on Form 10-Q are unaudited. The balance sheet as of June 30, 2022 is derived from the audited financial statements as of that date. The accompanying statements should be read in conjunction with the audited financial statements and related notes contained in Item 8 of the Company’s Annual Report on Form 10-K (the “2022 Annual Report”) for the fiscal year ended June 30, 2022 filed with the SEC on September 2, 2022.

The accompanying condensed consolidated financial statements as of March 31, 2023, for the three and nine months ended March 31, 2023 and 2022, and as of the fiscal year ended June 30, 2022, include the accounts of the Company and its wholly owned subsidiaries charlesandcolvard.com, LLC, including its wholly-owned subsidiary, moissaniteoulet.com, LLC, which was formed and incorporated as of February 24, 2022; Charles & Colvard Direct, LLC; and Charles & Colvard (HK) Ltd., the Company’s Hong Kong subsidiary, which was entered into dormancy as of September 30, 2020 following its re-activation in December 2017. Charles & Colvard (HK) Ltd. previously became dormant in the second quarter of 2009 and has had no operating activity since 2008. Charles & Colvard Direct, LLC, had no operating activity during the nine-month periods ended March 31, 2023 or 2022. All intercompany accounts have been eliminated.

Significant Accounting Policies – In the opinion of the Company’s management, except as discussed below, the Company’s significant accounting policies used for the three and nine months ended March 31, 2023, are consistent with those used for the fiscal year ended June 30, 2022. Accordingly, please refer to Note 2 to the Consolidated Financial Statements in the 2022 Annual Report for the Company’s significant accounting policies.

Use of Estimates – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. As future events and their effects, including any impact of the COVID-19 pandemic and the related responses, cannot be fully determined with precision, actual results of operations, cash flow, and financial position could differ significantly from estimates. The most significant estimates impacting the Company’s condensed consolidated financial statements relate to valuation and classification of inventories, accounts receivable reserves, deferred tax assets (including deferred tax asset valuation allowances), stock-based compensation, and revenue recognition. Changes in estimates are reflected in the condensed consolidated financial statements in the period in which the change in estimate occurs.

Cash and Cash Equivalents – All highly liquid investments with an original maturity of three months or less from the date of purchase are considered to be cash equivalents.

Restricted Cash – In accordance with the terms of the Company’s cash collateralized $5.00 million credit facility from JPMorgan Chase Bank, N.A. (“JPMorgan Chase”), which expires by its terms on July 31, 2023, the Company is required to keep $5.05 million in a cash deposit account held by JPMorgan Chase. Such amount is held as security for the Company’s credit facility from JPMorgan Chase. Accordingly, this cash deposit held by JPMorgan Chase is classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s cash collateralized credit facility, see Note 10, “Debt.”

Pursuant to the terms and conditions of the Company’s broker-dealer agreement with Oppenheimer & Co., Inc. (“Oppenheimer”), with whom the Company has engaged to transact common stock share repurchases in connection with its stock repurchase program, the Company is required to maintain a funded liquid margin account held by Oppenheimer for the benefit of the Company. The purpose of this account is to fund the Company’s common stock purchases and any underlying transaction costs and fees. Depending upon the level and timing of stock repurchase activity, the funded margin account cash balance will fluctuate from time to time. At March 31, 2023 and June 30, 2022, cash in the amount of approximately $30 and approximately $461,000, respectively, was held by Oppenheimer. Such cash amount held by Oppenheimer was classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s stock repurchase program, see Note 11, “Shareholders’ Equity and Stock-Based Compensation.”

The reconciliation of cash, cash equivalents, and restricted cash, as presented on the Condensed Consolidated Statements of Cash Flows, consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Cash and cash equivalents	$	10,914,584	$	15,668,361
Restricted cash		5,056,044		5,510,979
Total cash, cash equivalents, and restricted cash	$	15,970,628	$	21,179,340

XML

SEGMENT INFORMATION AND GEOGRAPHIC DATA

9 Months Ended

Mar. 31, 2023

SEGMENT INFORMATION AND GEOGRAPHIC DATA [Abstract]

SEGMENT INFORMATION AND GEOGRAPHIC DATA

3. SEGMENT INFORMATION AND GEOGRAPHIC DATA

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making operating decisions and assessing performance as the source of the Company’s operating and reportable segments.

The Company manages its business through two operating and reportable segments based on its distribution channels to sell its product lines, loose jewels and finished jewelry: its “Online Channels” segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets; and its “Traditional” segment, which consists of wholesale and retail customers, including its own Charles & Colvard Signature Showroom. The accounting policies of the Online Channels segment and Traditional segment are the same as those described in Note 2, “Basis of Presentation and Significant Accounting Policies” of this Quarterly Report on Form 10-Q and in the Notes to the Consolidated Financial Statements in the 2022 Annual Report.

The Company evaluates the financial performance of its segments based on net sales; product line gross profit, or the excess of product line sales over product line cost of goods sold; and operating income. The Company’s product line cost of goods sold is defined as product cost of goods sold, excluding non-capitalized expenses from the Company’s manufacturing and production control departments, comprising personnel costs, depreciation, leases, utilities, and corporate overhead allocations; freight out; inventory write-downs; and other inventory adjustments, comprising costs of quality issues, and damaged goods.

The Company allocates certain general and administrative expenses between its Online Channels segment and its Traditional segment based on net sales and number of employees to arrive at segment operating income. Unallocated expenses remain in its Traditional segment.

Summary financial information by reportable segment for the periods presented is as follows:

	Three Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	4,130,314		$	1,190,987		$	5,321,301
Loose jewels		486,084			834,414			1,320,498
Total	$	4,616,398		$	2,025,401		$	6,641,799
Product line cost of goods sold
Finished jewelry	$	1,880,504		$	959,817		$	2,840,321
Loose jewels		197,145			448,114			645,259
Total	$	2,077,649		$	1,407,931		$	3,485,580
Product line gross profit
Finished jewelry	$	2,249,810		$	231,170		$	2,480,980
Loose jewels		288,939			386,300			675,239
Total	$	2,538,749		$	617,470		$	3,156,219
Operating loss	$	(999,028	)	$	(1,173,091	)	$	(2,172,119	)
Depreciation and amortization	$	47,876		$	120,509		$	168,385
Capital expenditures	$	14,202		$	252,545		$	266,747

	Three Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	5,720,197	$	1,700,394	$	7,420,591
Loose jewels		634,617		1,696,627		2,331,244
Total	$	6,354,814	$	3,397,021	$	9,751,835
Product line cost of goods sold
Finished jewelry	$	2,560,952	$	1,148,912	$	3,709,864
Loose jewels		229,714		784,272		1,013,986
Total	$	2,790,666	$	1,933,184	$	4,723,850
Product line gross profit
Finished jewelry	$	3,159,245	$	551,482	$	3,710,727
Loose jewels		404,903		912,355		1,317,258
Total	$	3,564,148	$	1,463,837	$	5,027,985
Operating income	$	350,276	$	65,592	$	415,868
Depreciation and amortization	$	52,613	$	59,374	$	111,987
Capital expenditures	$	28,145	$	446,445	$	474,590

	Nine Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	15,657,343		$	3,640,572		$	19,297,915
Loose jewels		1,657,369			3,426,719			5,084,088
Total	$	17,314,712		$	7,067,291		$	24,382,003
Product line cost of goods sold
Finished jewelry	$	7,296,812		$	2,335,540		$	9,632,352
Loose jewels		623,129			1,719,004			2,342,133
Total	$	7,919,941		$	4,054,544		$	11,974,485
Product line gross profit
Finished jewelry	$	8,360,531		$	1,305,032		$	9,665,563
Loose jewels		1,034,240			1,707,715			2,741,955
Total	$	9,394,771		$	3,012,747		$	12,407,518
Operating income	$	(1,954,975	)	$	(2,683,786	)	$	(4,638,761	)
Depreciation and amortization	$	167,769		$	309,516		$	477,285
Capital expenditures	$	173,810		$	710,220		$	884,030

	Nine Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	18,659,690	$	4,986,354	$	23,646,044
Loose jewels		2,388,584		7,750,653		10,139,237
Total	$	21,048,274	$	12,737,007	$	33,785,281
Product line cost of goods sold
Finished jewelry	$	7,705,127	$	3,043,196	$	10,748,323
Loose jewels		877,604		3,630,393		4,507,997
Total	$	8,582,731	$	6,673,589	$	15,256,320
Product line gross profit
Finished jewelry	$	10,954,563	$	1,943,158	$	12,897,721
Loose jewels		1,510,980		4,120,260		5,631,240
Total	$	12,465,543	$	6,063,418	$	18,528,961
Operating income	$	2,104,674	$	711,123	$	2,815,797
Depreciation and amortization	$	173,786	$	176,412	$	350,198
Capital expenditures	$	114,445	$	1,135,851	$	1,250,296

The Company does not allocate any assets to the reportable segments, and, therefore, no asset information is reported to the chief operating decision maker or disclosed in the financial information for each segment.

A reconciliation of the Company’s product line cost of goods sold to cost of goods sold as reported in the condensed consolidated financial statements is as follows:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023		2022			2023		2022
Product line cost of goods sold	$	3,485,580	$	4,723,850		$	11,974,485	$	15,256,320
Non-capitalized manufacturing and production control expenses		596,344		484,299			1,660,231		1,243,528
Freight out		216,817		294,143			851,171		976,855
Inventory write-downs		-		-			119,000		232,000
Other inventory adjustments		194,384		(205,762	)		46,023		(361,677	)
Cost of goods sold	$	4,493,125	$	5,296,530		$	14,650,910	$	17,347,026

The Company recognizes sales by geographic area based on the country in which the customer is based. Sales to international end consumers made through the Company’s transactional websites, charlesandcolvard.com and moissaniteoutlet.com, are included in international sales for financial reporting purposes. A portion of the Company’s Traditional segment sales made to international wholesale distributors represents products sold internationally that may be re-imported to U.S. retailers.

The following presents net sales by geographic area:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Net sales
United States	$	6,545,336	$	9,390,774	$	23,630,410	$	32,237,221
International		96,463		361,061		751,593		1,548,060
Total	$	6,641,799	$	9,751,835	$	24,382,003	$	33,785,281

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Mar. 31, 2023

FAIR VALUE MEASUREMENTS [Abstract]

FAIR VALUE MEASUREMENTS

4. FAIR VALUE MEASUREMENTS

Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability. The fair value hierarchy consists of three levels based on the reliability of inputs, as follows:

Level 1.  Quoted prices in active markets for identical assets and liabilities;

Level 2.  Inputs other than Level 1 quoted prices that are directly or indirectly observable; and

Level 3.  Unobservable inputs that are not corroborated by market data.

The Company evaluates assets and liabilities subject to fair value measurements on a recurring and non-recurring basis to determine the appropriate level to classify them for each reporting period. This determination requires significant judgments to be made by management of the Company. The financial instruments identified as subject to fair value measurements on a recurring basis are cash and cash equivalents, notes receivable, trade accounts receivable, and trade accounts payable. All financial instruments are reflected in the condensed consolidated balance sheets at carrying value, which approximates fair value due to the nature of these financial instruments. Assets that are measured at fair value on a non-recurring basis include property and equipment, leasehold improvements, and intangible assets comprising patents, license rights, and trademarks. These items are recognized at fair value when they are considered to be impaired. For the three and nine months ended March 31, 2023 and 2022, no impairment was recorded.

XML

INVENTORIES

9 Months Ended

Mar. 31, 2023

INVENTORIES [Abstract]

INVENTORIES

5. INVENTORIES

The Company’s total inventories, net of reserves, consisted of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Finished jewelry:
Raw materials	$	1,359,919	$	1,697,361
Work-in-process		716,494		1,260,728
Finished goods		13,045,604		12,100,910
Finished goods on consignment		2,266,501		2,135,856
Total finished jewelry	$	17,388,518	$	17,194,855
Loose jewels:
Raw materials	$	812,024	$	1,985,355
Work-in-process		8,980,285		8,485,713
Finished goods		5,519,936		5,454,266
Finished goods on consignment		251,693		303,491
Total loose jewels		15,563,938		16,228,825
Total supplies inventory		376,830		89,120
Total inventory	$	33,329,286	$	33,512,800

As of the dates presented, the Company’s total inventories, net of reserves, are classified as follows:

	March 31, 2023		June 30, 2022
Short-term portion	$	7,889,917	$	11,024,276
Long-term portion		25,439,369		22,488,524
Total	$	33,329,286	$	33,512,800

The Company’s work-in-process inventories include raw SiC crystals on which processing costs, such as labor and sawing, have been incurred; and components, such as metal castings and finished goods set with moissanite jewels, that have been issued to jobs in the manufacture of finished jewelry. The Company’s moissanite jewel manufacturing process involves the production of intermediary shapes, called “preforms,” that vary depending upon the expected size and shape of the finished jewel. To maximize manufacturing efficiencies, preforms may be made in advance of current finished inventory needs but remain in work-in-process inventories. As of March 31, 2023 and June 30, 2022, work-in-process inventories issued to active production jobs approximated $1.41 million and $2.76 million, respectively.

The Company’s moissanite and lab grown diamond jewels do not degrade in quality over time and inventory generally consists of the shapes and sizes most commonly used in the jewelry industry. In addition, approximately one-half of the Company’s jewel inventory is not mounted in finished jewelry settings and is therefore not subject to fashion trends. Product obsolescence is closely monitored and reviewed by management as of and for each financial reporting period.

The Company manufactures finished jewelry featuring moissanite and lab grown diamonds. Relative to loose moissanite jewels and lab grown diamonds, finished jewelry is more fashion-oriented and subject to styling trends that could render certain designs obsolete over time. The majority of the Company’s finished jewelry featuring moissanite and lab grown diamonds is held in inventory for resale and largely consists of such core designs as stud earrings, solitaire and three-stone rings, pendants, and bracelets that tend not to be subject to significant obsolescence risk due to their classic styling. In addition, the Company generally holds smaller quantities of designer-inspired and trend moissanite fashion jewelry that is available for resale through retail companies and through its Online Channels segment. The Company also carries a limited amount of inventory as part of its sample line that the Company uses in the selling process to its customers.

The Company’s continuing operating subsidiaries carry no net inventories, and inventory is transferred without intercompany markup from the parent entity as product line cost of goods sold when sold to the end consumer.

The Company’s inventories are stated at the lower of cost or net realizable value on an average cost basis. Each accounting period the Company evaluates the valuation and classification of inventories including the need for potential adjustments to inventory-related reserves, which include significant estimates by management, including the effect of market factors and sales trends. Changes to the Company’s inventory reserves and allowances are accounted for in the accounting period in which a change in such reserves and allowances is observed and deemed appropriate, including changes in management’s estimates used in the process to determine such reserves and valuation allowances.

XML

NOTE RECEIVABLE

9 Months Ended

Mar. 31, 2023

NOTE RECEIVABLE [Abstract]

NOTE RECEIVABLE

6. NOTE RECEIVABLE

On March 5, 2021, the Company entered into a $250,000 convertible promissory note agreement (the “Convertible Promissory Note”), with an unrelated third-party strategic marketing partner. The Convertible Promissory Note is unsecured and was scheduled originally to mature on March 5, 2022. In February 2022, the Company entered into an amendment to the Convertible Promissory Note that was effective as of December 9, 2021 and changed the maturity date to September 30, 2022. Effective September 26, 2022, the Company further amended the Convertible Promissory Note (the “September 2022 Amendment”) and changed the maturity date to June 20, 2024 (the “Maturity Date”). Prior to the September 2022 Amendment, the Company accounted for the Convertible Promissory Note as a current note receivable within the accompanying condensed consolidated financial statements. However, in accordance with the terms of the September 2022 Amendment, the note receivable is classified as a noncurrent note receivable within the accompanying condensed consolidated financial statements as of March 31, 2023.

Interest is accrued at a simple rate of 0.14% per annum and will continue to accrue until the Convertible Promissory Note is converted in accordance with the conversion privileges contained within the Convertible Promissory Note or is repaid. Principal outstanding during an event of default accrues interest at the rate of 5% per annum. Prior to the September 2022 Amendment, accrued and unpaid interest on the Convertible Promissory Note was classified as a current asset and included in prepaid expenses and other assets in the accompanying condensed consolidated financial statements. In accordance with the terms of the September 2022 Amendment, accrued and unpaid interest on the Convertible Promissory Note is classified as a noncurrent asset and included in other noncurrent assets in the accompanying condensed consolidated financial statements as of March 31, 2023.

Subject to the borrower’s completion of a specified equity financing transaction (an “Equity Financing”) on or prior to the Maturity Date, the unpaid principal amount, including accrued and unpaid interest, automatically converts into equity units of the most senior class of equity securities issued to investors in the Equity Financing at the lesser of 80% of the per unit price of the units purchased by investors or the price equal to $33,500,000 divided by the aggregate number of outstanding units of the borrower immediately prior to the closing of the financing. Unless converted as provided in the Convertible Promissory Note, the principal amount, including accrued and unpaid interest, will, on the Maturity Date, at the Company’s option either (i) become due and payable to the Company, or (ii) convert into equity units at the specified conversion price in accordance with the terms of the Convertible Promissory Note.

XML

ACCRUED EXPENSES AND OTHER LIABILITIES

9 Months Ended

Mar. 31, 2023

ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]

ACCRUED EXPENSES AND OTHER LIABILITIES

7. ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Deferred revenue	$	434,132	$	452,866
Accrued compensation and related benefits		275,465		614,443
Accrued sales taxes and franchise taxes		233,351		341,706
Accrued cooperative advertising		200,243		137,467
Other accrued expenses		1		1
Total accrued expenses and other liabilities	$	1,143,192	$	1,546,483

XML

INCOME TAXES

9 Months Ended

Mar. 31, 2023

INCOME TAXES [Abstract]

INCOME TAXES

8. INCOME TAXES

As of each reporting date, management considers new evidence, both positive and negative, that could impact the Company’s view with regard to future realization of deferred tax assets. During the three months ended March 31, 2023, management determined that due to the worsening global macro-economic conditions and heightened levels of inflation, including fears of recession, coupled with the effects from worldwide political unrest and the ongoing economic impact from the COVID pandemic, the risks associated with these conditions led management to conclude that it was not more likely than not the Company would have sufficient future taxable income to utilize its deferred tax assets. Additionally, the Company’s management determined that the positive evidence was no longer sufficient to offset available negative evidence, primarily as a result of the pre-tax operating losses incurred during the three- and nine-month periods ended March 31, 2023. Consequently, management established a full valuation allowance against the Company’s deferred tax assets, resulting in an income tax expense of approximately $6.29 million and $5.86 million for the three and nine months ended March 31, 2023, respectively. The Company recognized an income tax expense of approximately $78,000 and $485,000 for the three and nine months ended March 31, 2022, respectively.

The Company’s effective income tax rate reflects the effect of federal and state income taxes on earnings and the impact of differences in book and tax accounting arising primarily from the permanent tax benefits associated with stock-based compensation transactions during the quarter. Driven by the establishment of the valuation allowance during the quarter ended March 31, 2023, the Company’s effective tax rate for the nine month-period then ended was a negative 131.06%. For the nine months ended March 31, 2022, the Company’s effective tax rate was 17.20%.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Mar. 31, 2023

COMMITMENTS AND CONTINGENCIES [Abstract]

COMMITMENTS AND CONTINGENCIES

9. COMMITMENTS AND CONTINGENCIES

Lease Arrangements

On December 9, 2013, the Company entered into a Lease Agreement, as amended on December 23, 2013, April 15, 2014, and January 29, 2021 (the “Lease Agreement”), for its corporate headquarters, which occupies approximately 36,350 square feet of office, storage and light manufacturing space and is classified as an operating lease for financial reporting purposes. The expiration date of the base term of the Lease Agreement is October 31, 2026 and the terms of the Lease Agreement contain no early termination provisions. Provided there is no outstanding uncured event of default under the Lease Agreement, the Company has an option to extend the lease term for a period of five years. The Company’s option to extend the term of the Lease Agreement must be exercised in writing on or before 270 days prior to expiration of the then-current term. If the option is exercised, the monthly minimum rent for each of the extended terms will be adjusted to the then prevailing fair market rate.

The Company took possession of the leased property on May 23, 2014, once certain improvements to the leased space were completed and did not have access to the property before this date. Upon execution of the third amendment to the Lease Agreement (the “Lease Amendment”) on January 29, 2021, the Lease Amendment included a rent abatement in the amount of approximately $214,000, which is reflected in the rent payments used in the calculation of the right-of-use (“ROU”) asset and lease liability once remeasured upon the execution of the Lease Amendment to extend the lease term. The Lease Amendment also included an allowance for leasehold improvements offered by the landlord in an amount not to exceed approximately $545,000. As of the quarter ended March 31, 2023, the Company has been reimbursed approximately $506,000 by the landlord for qualified leasehold improvements in accordance with the terms of the Lease Amendment. This reimbursement by the landlord reduced the remaining ROU asset by the same amount and is being recognized prospectively over the remaining term of the lease.

The Company has no other material operating leases and is not party to leases that would qualify for classification as a finance lease, variable lease, or short-term lease.

As of March 31, 2023, the Company’s balance sheet classifications of its leases are as follows:

Operating Leases:
Noncurrent operating lease ROU assets	$	2,336,334
Current operating lease liabilities	$	874,177
Noncurrent operating lease liabilities		2,251,581
Total operating lease liabilities	$	3,125,758

The Company’s total operating lease cost was approximately $193,000 for each of the three months ended March 31, 2023 and 2022. The Company’s total operating lease cost was approximately $578,000 and $596,000 for the nine months ended March 31, 2023 and 2022, respectively.

The Company’s estimated incremental borrowing rate used and assumed discount rate with respect to operating leases was 2.81% and the remaining operating lease term was 3.58 years.

As of March 31, 2023, Company’s remaining future payments under operating leases for each fiscal year ending June 30 are as follows:

2023	$	219,393
2024		893,660
2025		918,236
2026		943,487
2027		317,327
Total lease payments		3,292,103
Less: imputed interest		166,345
Present value of lease payments		3,125,758
Less: current lease liability		874,177
Total long-term lease liability	$	2,251,581

The Company makes cash payments for amounts included in the measurement of its lease liabilities. During the three months ended March 31, 2023 and 2022, cash paid for operating leases was approximately $237,000 and $160,000, respectively. During the nine months ended March 31, 2023 and 2022, cash paid for operating leases was approximately $704,000 and $330,000, respectively.

Purchase Commitments

On December 12, 2014, the Company entered into an exclusive supply agreement (the “Supply Agreement”) with Wolfspeed, Inc. (“Wolfspeed”). Under the Supply Agreement, subject to certain terms and conditions, the Company agreed to exclusively purchase from Wolfspeed, and Wolfspeed agreed to exclusively supply, 100% of the Company’s required SiC materials in quarterly installments that must equal or exceed a set minimum order quantity. The initial term of the Supply Agreement was scheduled to expire on June 24, 2018, unless extended by the parties.

Effective June 22, 2018, the Supply Agreement was amended to extend the expiration date to June 25, 2023. The Supply Agreement was also amended to (i) provide the Company with one option, subject to certain conditions, to unilaterally extend the term of the Supply Agreement for an additional two-year period following expiration of the initial term; (ii) establish a process by which Wolfspeed may begin producing alternate SiC material based on the Company’s specifications that will give the Company the flexibility to use the materials in a broader variety of its products; and (iii) permit the Company to purchase certain amounts of SiC materials from third parties under limited conditions.

Effective June 30, 2020, the Supply Agreement was further amended to extend the expiration date to June 29, 2025, which may be extended again by mutual agreement of the parties. The Supply Agreement was also amended to, among other things, (i) spread the Company’s total purchase commitment under the Supply Agreement in the amount of approximately $52.95 million over the term of the Supply Agreement, as amended; (ii) establish a process by which Wolfspeed has agreed to accept purchase orders in excess of the agreed-upon minimum purchase commitment, subject to certain conditions; and (iii) permit the Company to purchase revised amounts of SiC materials from third parties under limited conditions.

The Company’s total purchase commitment under the Supply Agreement, as amended, until June 2025 is approximately $52.95 million, of which approximately $24.75 million remains to be purchased as of March 31, 2023. Over the life of the Supply Agreement, as amended, the Company’s future minimum annual purchase commitments of SiC crystals range from approximately $4.00 million to $10.00 million each year.

During the nine months ended March 31, 2023 and 2022, the Company purchased approximately $1.80 million and $4.49 million, respectively, of SiC crystals from Wolfspeed pursuant to the terms of the Supply Agreement, as amended. The Company has made no purchases of SiC crystals during the six-month period ended March 31, 2023 while currently in discussions regarding the terms of the Supply Agreement.

Inflation

Heightened levels of inflation and the potential worsening of macro-economic conditions present a risk for the Company, its suppliers, and the stability of the broader retail and e-commerce industry. During the first nine months of Fiscal 2023, the Company has experienced impacts to its labor and overhead rates and suppliers have signaled inflation related cost pressures, which is expected to flow through to the Company’s costs and pricing. While the Company has seen adverse impact from inflation on its financial results in the first nine months of Fiscal 2023, if inflation remains at current levels for an extended period, or increases, and the Company is unable to successfully mitigate the impact, the Company’s costs are likely to continue to increase, resulting in further pressure on its revenues, margins, and cash flows. In addition, inflation and the increases in the cost of borrowing from rising interest rates could constrain the overall purchasing power of the Company’s customers for its products and services, in particular in the near term to the extent inflation assumptions are less than current inflationary pressures.

XML

DEBT

9 Months Ended

Mar. 31, 2023

DEBT [Abstract]

DEBT

10. DEBT

Line of Credit

Effective July 7, 2021, the Company obtained from JPMorgan Chase a $5.00 million cash collateralized line of credit facility (the “JPMorgan Chase Credit Facility”). The JPMorgan Chase Credit Facility may be used for general corporate and working capital purposes, including permitted acquisitions and certain additional indebtedness for borrowed money, installment obligations, and obligations under capital and operating leases. The JPMorgan Chase Credit Facility is secured by a cash deposit in the amount of $5.05 million held by JPMorgan Chase as collateral for the line of credit facility and was scheduled to mature on July 31, 2022. Effective July 28, 2022, the JPMorgan Chase Credit Facility was amended to, among other things, extend the maturity date to July 31, 2023, and append the Company’s obligations under the JPMorgan Chase Credit Facility to be guaranteed by the Company’s wholly owned subsidiaries, Charles & Colvard Direct, LLC, charlesandcolvard.com, LLC, and moissaniteoutlet.com, LLC.

Each advance under the JPMorgan Chase Credit Facility, as amended, accrues interest at a rate equal to the sum of JPMorgan Chase’s monthly secured overnight financing rate (“SOFR rate”) to which JPMorgan Chase is subject with respect to the adjusted SOFR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum and an unsecured to secured interest rate adjustment of 0.10% per annum. Prior to its amendment, each advance under the JPMorgan Chase Credit Facility would have accrued interest at a rate equal to JPMorgan Chase’s monthly LIBOR rate multiplied by a statutory reserve rate for eurocurrency funding to which JPMorgan Chase is subject with respect to the adjusted LIBOR rate as established by the U.S. Federal Reserve Board, plus a margin of 1.25% per annum. Interest is calculated monthly on an actual/360-day basis and payable monthly in arrears. Principal outstanding during an event of default, at JPMorgan Chase’s option, accrues interest at a rate of 3.00% per annum in excess of the above rate. Any advance may be prepaid in whole or in part without penalty at any time.

As of March 31, 2023, the Company had not borrowed against the JPMorgan Chase Credit Facility and had no outstanding debt as of the period then ended.

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION

9 Months Ended

Mar. 31, 2023

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION [Abstract]

SHAREHOLDERS' EQUITY

11. SHAREHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION

Repurchases of Common Stock 

Pursuant to authority granted by the Company’s Board of Directors on April 29, 2022, the Company can repurchase up to approximately $5.00 million in shares outstanding of the Company’s common stock over the three-year period ending April 29, 2025. Pursuant to the terms of the repurchase authorization, the common stock share repurchases are generally at the discretion of the Company’s management. As the Company repurchases its common shares, which have no par value, the Company reports such shares held as treasury stock in the accompanying condensed consolidated balance sheets with the purchase price recorded within treasury stock.

During the nine-month period ended March 31, 2023, the Company repurchased 358,116 shares of the Company’s common stock for an aggregate price of $451,815 pursuant to the repurchase authorization. The Company repurchased no shares of the Company’s common stock during the three-month period ended March 31, 2023.

Dividends

The Company has paid no cash dividends during the current fiscal year through March 31, 2023.

STOCK-BASED COMPENSATION

Stock-Based Compensation

The following table summarizes the components of the Company’s stock-based compensation included in net income for the periods presented:

	Three Months Ended March 31,							Nine Months Ended March 31,
	2023				2022			2023			2022
Employee stock options		$	63,383			$	60,045		$	185,585		$	187,059
Restricted stock awards			(28,789	)			138,478			23,734			489,875
Totals		$	34,594			$	198,523		$	209,319		$	676,934

No stock-based compensation was capitalized as a cost of inventory during the three and nine months ended March 31, 2023 and 2022.

Stock Options –The following is a summary of the stock option activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Exercise Price
Outstanding, June 30, 2022		1,658,803		$	1.32
Granted		270,787		$	1.02
Forfeited		(22,004	)	$	2.01
Expired		(3,663	)	$	1.01
Outstanding, March 31, 2023		1,903,923		$	1.27

The weighted average grant date fair value of stock options granted during the nine months ended March 31, 2023 and 2022 was approximately $0.59 and $1.37, respectively. The total fair value of stock options that vested during the nine months ended March 31, 2023 and 2022 was approximately $225,000 and $188,000, respectively.

The following table summarizes information about stock options outstanding at March 31, 2023:

Options Outstanding						Options Exercisable						Options Vested or Expected to Vest
Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price
	1,903,923		6.61	$	1.27		1,440,913		5.81	$	1.24		1,859,855		6.56	$	1.26

As of March 31, 2023, the unrecognized stock-based compensation expense related to unvested stock options was approximately $256,000, which is expected to be recognized over a weighted average period of approximately 18 months.

The aggregate intrinsic value of stock options outstanding, exercisable, and vested or expected to vest at March 31, 2023 and 2022 was approximately $101,000 and $973,000, respectively. These amounts are before applicable income taxes and represent the closing market price of the Company’s common stock at March 31, 2023 less the grant price, multiplied by the number of stock options that had a grant price that is less than the closing market price. These values represent the amount that would have been received by the optionees had these stock options been exercised on that date. During the nine months ended March 31, 2022, the aggregate intrinsic value of stock options exercised was approximately $829,000. During the nine months ended March 31, 2022, the total estimated tax benefit associated with certain stock options that were exercised was approximately $93,000. No stock options were exercised during the nine-month period ended March 31, 2023.

Restricted Stock

The following is a summary of the restricted stock activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Grant Date Fair Value
Unvested, June 30, 2022		178,750		$	2.75
Granted		178,750		$	0.97
Vested		(134,063	)		2.75
Cancelled		(44,687	)	$	2.75
Unvested, March 31, 2023		178,750		$	0.97

The unvested restricted shares as of March 31, 2023 are all performance-based restricted shares and were scheduled to vest, subject to achievement of the underlying performance goals, in July 2023. However, during the quarter ended March 31, 2023, it was determined that none of the underlying performance-based targets related to the unvested restricted shares would be achieved for Fiscal 2023 and management concluded that none of the restricted shares would vest. Accordingly, the underlying expected forfeiture rates were adjusted to reflect the change in estimate. In addition, the benefit in stock-based compensation expense from the reversal of previously recorded stock-based compensation on these performance-based awards related to the unvested restricted shares was recognized in the current quarter ended March 31, 2023. As of March 31, 2023, the estimated unrecognized stock-based compensation expense related to unvested restricted shares subject to achievement of performance goals was approximately $173,000, none of which is expected to be recognized over the weighted average period of approximately four months.

XML

NET (LOSS) INCOME PER COMMON SHARE

9 Months Ended

Mar. 31, 2023

NET (LOSS) INCOME PER COMMON SHARE [Abstract]

NET (LOSS) INCOME PER COMMON SHARE

12. NET (LOSS) INCOME PER COMMON SHARE

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the periods. Diluted net income per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options and unvested restricted shares that are computed using the treasury stock method. Anti-dilutive stock awards consist of stock options that would have been anti-dilutive in the application of the treasury stock method.

The following table reconciles the differences between the basic and diluted net (loss) income per share presentations:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023			2022		2023			2022
Numerator:
Net (loss)income	$	(8,396,008	)	$	338,508	$	(10,327,981	)	$	2,333,145
Denominator:
Weighted average common shares outstanding:
Basic		30,344,954			30,484,897		30,387,303			30,286,195
Effect of dilutive securities		-			783,513		-			985,482
Diluted		30,344,954			31,268,410		30,387,303			31,271,677
Net (loss) income per common share:
Basic	$	(0.28	)	$	0.01	$	(0.34	)	$	0.08
Diluted	$	(0.28	)	$	0.01	$	(0.34	)	$	0.07

For the three and nine months ended March 31, 2023, stock options to purchase approximately 1.90 million shares were excluded from the computation of diluted net loss per common share because the effect of inclusion of such amounts would be anti-dilutive to net loss per common share. For the three and nine months ended March 31, 2022, stock options to purchase approximately 975,000 shares and 773,000 shares, respectively, were excluded from the computation of diluted net income per common share for each period presented herein. These shares were excluded from the computation of diluted net income per common share because the exercise price of the stock options for the period presented herein was greater than the average market price of the common shares or the effect of inclusion of such amounts would be anti-dilutive to net income per common share. Approximately 179,000 shares of unvested restricted stock are excluded from the computation of basic net (loss) income and diluted net (loss) income per common share as of both March 31, 2023 and 2022 because the shares are performance-based and the underlying conditions had not been met as of the periods presented herein.

XML

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK

9 Months Ended

Mar. 31, 2023

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK [Abstract]

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK

13. MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash on deposit and cash equivalents held with banks and trade accounts receivable. The Company places cash deposits with federally insured financial institutions and maintains its cash at banks and financial institutions it considers to be of high credit quality. However, the Company’s cash deposits may at times exceed the Federal Deposit Insurance Corporation’s insurable limits. Accordingly, balances in excess of federally insured limitations may not be insured. The Company has not experienced losses on these accounts, and management believes that the Company is not exposed to significant risks on such accounts.

Trade receivables potentially subject the Company to credit risk. Payment terms on trade receivables for the Company’s Traditional segment customers are generally between 30 and 90 days, though it may offer extended terms with specific customers and on significant orders from time to time. The Company extends credit to its customers based upon a number of factors, including an evaluation of the customer’s financial condition and credit history that is verified through trade association reference services, the customer’s payment history with the Company, the customer’s reputation in the trade, and/or an evaluation of the Company’s opportunity to introduce its moissanite jewels or finished jewelry featuring moissanite and lab grown diamonds to new or expanded markets. Collateral is not generally required from customers. The need for an allowance for doubtful accounts is determined based upon factors surrounding the credit risk of specific customers, historical trends, and other information. For additional information regarding the Company’s measurement and disclosure of credit losses on financial assets, including trade accounts receivable, see Note 4, “Fair Value Measurements.”

At times, a portion of the Company’s accounts receivable will be due from customers that have individual balances of 10% or more of the Company’s total gross accounts receivable.

The following is a summary of customers that represent 10% or more of total gross accounts receivable as of the dates presented:

	March 31, 2023			June 30, 2022
Customer A		24	%		20	%
Customer B		18	%		29	%
Customer C		15	%		**	%
Customer D		*	%		13	%

* Customer D did not have individual balances that represented 10% or more of total gross accounts receivable as of March 31, 2023.

** Customer C did not have individual balances that represented 10% or more of total gross accounts receivable as of June 30, 2022.

A significant portion of sales is derived from certain customer relationships. The following is a summary of customers that represent greater than or equal to 10% of total net sales for the periods presented:

	Three Months Ended March 31,						Nine Months Ended March 31,
	2023			2022			2023			2022
Customer A		13	%		13	%		14	%		15	%

XML

SUBSEQUENT EVENT

9 Months Ended

Mar. 31, 2023

SUBSEQUENT EVENT [Abstract]

SUBSEQUENT EVENT

14. SUBSEQUENT EVENT

As previously disclosed, on December 19, 2022, management received notice from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq’s listing requirements because the minimum bid price of its common stock on The Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days. In accordance with the Nasdaq’s listing requirements, the Company had 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement.

On April 20, 2023, the Company’s management received a letter from the Nasdaq Listing Qualifications Department notifying the Company that the minimum bid price of its common stock was $1.00 per share or greater for at least the last 10 consecutive business days. Accordingly, the Company has regained compliance with the Nasdaq minimum bid price requirement and the matter is now closed.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Mar. 31, 2023

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. However, certain information or footnote disclosures normally included in complete financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q include all normal and recurring adjustments necessary for the fair statement of the results for the interim periods presented. The results for the nine months ended March 31, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending June 30, 2023 (“Fiscal 2023”).

The condensed consolidated financial statements as of March 31, 2023 and for the three and nine months ended March 31, 2023 and 2022 included in this Quarterly Report on Form 10-Q are unaudited. The balance sheet as of June 30, 2022 is derived from the audited financial statements as of that date. The accompanying statements should be read in conjunction with the audited financial statements and related notes contained in Item 8 of the Company’s Annual Report on Form 10-K (the “2022 Annual Report”) for the fiscal year ended June 30, 2022 filed with the SEC on September 2, 2022.

Principles of Consolidation

The accompanying condensed consolidated financial statements as of March 31, 2023, for the three and nine months ended March 31, 2023 and 2022, and as of the fiscal year ended June 30, 2022, include the accounts of the Company and its wholly owned subsidiaries charlesandcolvard.com, LLC, including its wholly-owned subsidiary, moissaniteoulet.com, LLC, which was formed and incorporated as of February 24, 2022; Charles & Colvard Direct, LLC; and Charles & Colvard (HK) Ltd., the Company’s Hong Kong subsidiary, which was entered into dormancy as of September 30, 2020 following its re-activation in December 2017. Charles & Colvard (HK) Ltd. previously became dormant in the second quarter of 2009 and has had no operating activity since 2008. Charles & Colvard Direct, LLC, had no operating activity during the nine-month periods ended March 31, 2023 or 2022. All intercompany accounts have been eliminated.

Use of Estimates

Use of Estimates – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. As future events and their effects, including any impact of the COVID-19 pandemic and the related responses, cannot be fully determined with precision, actual results of operations, cash flow, and financial position could differ significantly from estimates. The most significant estimates impacting the Company’s condensed consolidated financial statements relate to valuation and classification of inventories, accounts receivable reserves, deferred tax assets (including deferred tax asset valuation allowances), stock-based compensation, and revenue recognition. Changes in estimates are reflected in the condensed consolidated financial statements in the period in which the change in estimate occurs.

Cash and Cash Equivalents

Cash and Cash Equivalents – All highly liquid investments with an original maturity of three months or less from the date of purchase are considered to be cash equivalents.

Restricted Cash

Restricted Cash – In accordance with the terms of the Company’s cash collateralized $5.00 million credit facility from JPMorgan Chase Bank, N.A. (“JPMorgan Chase”), which expires by its terms on July 31, 2023, the Company is required to keep $5.05 million in a cash deposit account held by JPMorgan Chase. Such amount is held as security for the Company’s credit facility from JPMorgan Chase. Accordingly, this cash deposit held by JPMorgan Chase is classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s cash collateralized credit facility, see Note 10, “Debt.”

Pursuant to the terms and conditions of the Company’s broker-dealer agreement with Oppenheimer & Co., Inc. (“Oppenheimer”), with whom the Company has engaged to transact common stock share repurchases in connection with its stock repurchase program, the Company is required to maintain a funded liquid margin account held by Oppenheimer for the benefit of the Company. The purpose of this account is to fund the Company’s common stock purchases and any underlying transaction costs and fees. Depending upon the level and timing of stock repurchase activity, the funded margin account cash balance will fluctuate from time to time. At March 31, 2023 and June 30, 2022, cash in the amount of approximately $30 and approximately $461,000, respectively, was held by Oppenheimer. Such cash amount held by Oppenheimer was classified as restricted cash for financial reporting purposes on the Company’s condensed consolidated balance sheets. For additional information regarding the Company’s stock repurchase program, see Note 11, “Shareholders’ Equity and Stock-Based Compensation.”

The reconciliation of cash, cash equivalents, and restricted cash, as presented on the Condensed Consolidated Statements of Cash Flows, consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Cash and cash equivalents	$	10,914,584	$	15,668,361
Restricted cash		5,056,044		5,510,979
Total cash, cash equivalents, and restricted cash	$	15,970,628	$	21,179,340

Reclassification

Reclassification – Certain amounts in the Company’s condensed consolidated financial statements as of June 30, 2022 have been reclassified to conform to current presentation, principally amounts presented in Note 7, “Accrued Expenses and Other Liabilities”, relating to the combination of accrued sales tax and accrued franchise taxes, which had previously been presented separately. These reclassifications had no impact on the Company’s condensed consolidated financial position or condensed consolidated results of operations as of or for the three and nine months ended March 31, 2023 and 2022 and as of June 30, 2022.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Mar. 31, 2023

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Cash, Cash Equivalents and Restricted Cash

The reconciliation of cash, cash equivalents, and restricted cash, as presented on the Condensed Consolidated Statements of Cash Flows, consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Cash and cash equivalents	$	10,914,584	$	15,668,361
Restricted cash		5,056,044		5,510,979
Total cash, cash equivalents, and restricted cash	$	15,970,628	$	21,179,340

XML

SEGMENT INFORMATION AND GEOGRAPHIC DATA (Tables)

9 Months Ended

Mar. 31, 2023

SEGMENT INFORMATION AND GEOGRAPHIC DATA [Abstract]

Summary Financial Information by Reportable Segment

Summary financial information by reportable segment for the periods presented is as follows:

	Three Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	4,130,314		$	1,190,987		$	5,321,301
Loose jewels		486,084			834,414			1,320,498
Total	$	4,616,398		$	2,025,401		$	6,641,799
Product line cost of goods sold
Finished jewelry	$	1,880,504		$	959,817		$	2,840,321
Loose jewels		197,145			448,114			645,259
Total	$	2,077,649		$	1,407,931		$	3,485,580
Product line gross profit
Finished jewelry	$	2,249,810		$	231,170		$	2,480,980
Loose jewels		288,939			386,300			675,239
Total	$	2,538,749		$	617,470		$	3,156,219
Operating loss	$	(999,028	)	$	(1,173,091	)	$	(2,172,119	)
Depreciation and amortization	$	47,876		$	120,509		$	168,385
Capital expenditures	$	14,202		$	252,545		$	266,747

	Three Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	5,720,197	$	1,700,394	$	7,420,591
Loose jewels		634,617		1,696,627		2,331,244
Total	$	6,354,814	$	3,397,021	$	9,751,835
Product line cost of goods sold
Finished jewelry	$	2,560,952	$	1,148,912	$	3,709,864
Loose jewels		229,714		784,272		1,013,986
Total	$	2,790,666	$	1,933,184	$	4,723,850
Product line gross profit
Finished jewelry	$	3,159,245	$	551,482	$	3,710,727
Loose jewels		404,903		912,355		1,317,258
Total	$	3,564,148	$	1,463,837	$	5,027,985
Operating income	$	350,276	$	65,592	$	415,868
Depreciation and amortization	$	52,613	$	59,374	$	111,987
Capital expenditures	$	28,145	$	446,445	$	474,590

	Nine Months Ended March 31, 2023
	Online Channels			Traditional			Total
Net sales
Finished jewelry	$	15,657,343		$	3,640,572		$	19,297,915
Loose jewels		1,657,369			3,426,719			5,084,088
Total	$	17,314,712		$	7,067,291		$	24,382,003
Product line cost of goods sold
Finished jewelry	$	7,296,812		$	2,335,540		$	9,632,352
Loose jewels		623,129			1,719,004			2,342,133
Total	$	7,919,941		$	4,054,544		$	11,974,485
Product line gross profit
Finished jewelry	$	8,360,531		$	1,305,032		$	9,665,563
Loose jewels		1,034,240			1,707,715			2,741,955
Total	$	9,394,771		$	3,012,747		$	12,407,518
Operating income	$	(1,954,975	)	$	(2,683,786	)	$	(4,638,761	)
Depreciation and amortization	$	167,769		$	309,516		$	477,285
Capital expenditures	$	173,810		$	710,220		$	884,030

	Nine Months Ended March 31, 2022
	Online Channels		Traditional		Total
Net sales
Finished jewelry	$	18,659,690	$	4,986,354	$	23,646,044
Loose jewels		2,388,584		7,750,653		10,139,237
Total	$	21,048,274	$	12,737,007	$	33,785,281
Product line cost of goods sold
Finished jewelry	$	7,705,127	$	3,043,196	$	10,748,323
Loose jewels		877,604		3,630,393		4,507,997
Total	$	8,582,731	$	6,673,589	$	15,256,320
Product line gross profit
Finished jewelry	$	10,954,563	$	1,943,158	$	12,897,721
Loose jewels		1,510,980		4,120,260		5,631,240
Total	$	12,465,543	$	6,063,418	$	18,528,961
Operating income	$	2,104,674	$	711,123	$	2,815,797
Depreciation and amortization	$	173,786	$	176,412	$	350,198
Capital expenditures	$	114,445	$	1,135,851	$	1,250,296

Reconciliation of Product Line Cost of Goods Sold

A reconciliation of the Company’s product line cost of goods sold to cost of goods sold as reported in the condensed consolidated financial statements is as follows:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023		2022			2023		2022
Product line cost of goods sold	$	3,485,580	$	4,723,850		$	11,974,485	$	15,256,320
Non-capitalized manufacturing and production control expenses		596,344		484,299			1,660,231		1,243,528
Freight out		216,817		294,143			851,171		976,855
Inventory write-downs		-		-			119,000		232,000
Other inventory adjustments		194,384		(205,762	)		46,023		(361,677	)
Cost of goods sold	$	4,493,125	$	5,296,530		$	14,650,910	$	17,347,026

Net Sales by Geographic Area

The following presents net sales by geographic area:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Net sales
United States	$	6,545,336	$	9,390,774	$	23,630,410	$	32,237,221
International		96,463		361,061		751,593		1,548,060
Total	$	6,641,799	$	9,751,835	$	24,382,003	$	33,785,281

XML

INVENTORIES (Tables)

9 Months Ended

Mar. 31, 2023

INVENTORIES [Abstract]

Inventories

The Company’s total inventories, net of reserves, consisted of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Finished jewelry:
Raw materials	$	1,359,919	$	1,697,361
Work-in-process		716,494		1,260,728
Finished goods		13,045,604		12,100,910
Finished goods on consignment		2,266,501		2,135,856
Total finished jewelry	$	17,388,518	$	17,194,855
Loose jewels:
Raw materials	$	812,024	$	1,985,355
Work-in-process		8,980,285		8,485,713
Finished goods		5,519,936		5,454,266
Finished goods on consignment		251,693		303,491
Total loose jewels		15,563,938		16,228,825
Total supplies inventory		376,830		89,120
Total inventory	$	33,329,286	$	33,512,800

As of the dates presented, the Company’s total inventories, net of reserves, are classified as follows:

	March 31, 2023		June 30, 2022
Short-term portion	$	7,889,917	$	11,024,276
Long-term portion		25,439,369		22,488,524
Total	$	33,329,286	$	33,512,800

XML

ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)

9 Months Ended

Mar. 31, 2023

ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following as of the dates presented:

	March 31, 2023		June 30, 2022
Deferred revenue	$	434,132	$	452,866
Accrued compensation and related benefits		275,465		614,443
Accrued sales taxes and franchise taxes		233,351		341,706
Accrued cooperative advertising		200,243		137,467
Other accrued expenses		1		1
Total accrued expenses and other liabilities	$	1,143,192	$	1,546,483

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Mar. 31, 2023

COMMITMENTS AND CONTINGENCIES [Abstract]

Balance Sheet Classifications of Leases

As of March 31, 2023, the Company’s balance sheet classifications of its leases are as follows:

Operating Leases:
Noncurrent operating lease ROU assets	$	2,336,334
Current operating lease liabilities	$	874,177
Noncurrent operating lease liabilities		2,251,581
Total operating lease liabilities	$	3,125,758

Remaining Future Payments Under Operating Leases

As of March 31, 2023, Company’s remaining future payments under operating leases for each fiscal year ending June 30 are as follows:

2023	$	219,393
2024		893,660
2025		918,236
2026		943,487
2027		317,327
Total lease payments		3,292,103
Less: imputed interest		166,345
Present value of lease payments		3,125,758
Less: current lease liability		874,177
Total long-term lease liability	$	2,251,581

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Mar. 31, 2023

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION [Abstract]

Stock-Based Compensation

The following table summarizes the components of the Company’s stock-based compensation included in net income for the periods presented:

	Three Months Ended March 31,							Nine Months Ended March 31,
	2023				2022			2023			2022
Employee stock options		$	63,383			$	60,045		$	185,585		$	187,059
Restricted stock awards			(28,789	)			138,478			23,734			489,875
Totals		$	34,594			$	198,523		$	209,319		$	676,934

Stock Option Activity

Stock Options –The following is a summary of the stock option activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Exercise Price
Outstanding, June 30, 2022		1,658,803		$	1.32
Granted		270,787		$	1.02
Forfeited		(22,004	)	$	2.01
Expired		(3,663	)	$	1.01
Outstanding, March 31, 2023		1,903,923		$	1.27

Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2023:

Options Outstanding						Options Exercisable						Options Vested or Expected to Vest
Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Balance as of March 31, 2023		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price
	1,903,923		6.61	$	1.27		1,440,913		5.81	$	1.24		1,859,855		6.56	$	1.26

Restricted Stock Activity

The following is a summary of the restricted stock activity for the nine months ended March 31, 2023:

	Shares			Weighted Average Grant Date Fair Value
Unvested, June 30, 2022		178,750		$	2.75
Granted		178,750		$	0.97
Vested		(134,063	)		2.75
Cancelled		(44,687	)	$	2.75
Unvested, March 31, 2023		178,750		$	0.97

XML

NET (LOSS) INCOME PER COMMON SHARE (Tables)

9 Months Ended

Mar. 31, 2023

NET (LOSS) INCOME PER COMMON SHARE [Abstract]

Basic and Diluted Net (Loss) Income per Share

The following table reconciles the differences between the basic and diluted net (loss) income per share presentations:

	Three Months Ended March 31,					Nine Months Ended March 31,
	2023			2022		2023			2022
Numerator:
Net (loss)income	$	(8,396,008	)	$	338,508	$	(10,327,981	)	$	2,333,145
Denominator:
Weighted average common shares outstanding:
Basic		30,344,954			30,484,897		30,387,303			30,286,195
Effect of dilutive securities		-			783,513		-			985,482
Diluted		30,344,954			31,268,410		30,387,303			31,271,677
Net (loss) income per common share:
Basic	$	(0.28	)	$	0.01	$	(0.34	)	$	0.08
Diluted	$	(0.28	)	$	0.01	$	(0.34	)	$	0.07

XML

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK (Tables)

9 Months Ended

Mar. 31, 2023

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK [Abstract]

Major Customers

The following is a summary of customers that represent 10% or more of total gross accounts receivable as of the dates presented:

	March 31, 2023			June 30, 2022
Customer A		24	%		20	%
Customer B		18	%		29	%
Customer C		15	%		**	%
Customer D		*	%		13	%

* Customer D did not have individual balances that represented 10% or more of total gross accounts receivable as of March 31, 2023.

** Customer C did not have individual balances that represented 10% or more of total gross accounts receivable as of June 30, 2022.

A significant portion of sales is derived from certain customer relationships. The following is a summary of customers that represent greater than or equal to 10% of total net sales for the periods presented:

	Three Months Ended March 31,						Nine Months Ended March 31,
	2023			2022			2023			2022
Customer A		13	%		13	%		14	%		15	%

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021
Restricted Cash [Abstract]
Funded liquid margin account	$ 30	$ 461,000
Cash, Cash Equivalents and Restricted Cash [Abstract]
Cash and cash equivalents	10,914,584	15,668,361
Restricted cash	5,056,044	5,510,979
Total cash, cash equivalents, and restricted cash	15,970,628	$ 21,179,340	$ 21,911,685	$ 21,446,951
JPMorgan Chase Credit Facility [Member]
Restricted Cash [Abstract]
Borrowing capacity	5,000,000
Cash deposit	$ 5,050,000.00

XML

SEGMENT INFORMATION AND GEOGRAPHIC DATA, Summary Financial Information by Reportable Segment (Details)	3 Months Ended		9 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) Segment	Mar. 31, 2022 USD ($)
SEGMENT INFORMATION AND GEOGRAPHIC DATA [Abstract]
Number of operating segments | Segment			2
Number of reportable segments | Segment			2
Summary Information by Reportable Segment [Abstract]
Net sales	$ 6,641,799	$ 9,751,835	$ 24,382,003	$ 33,785,281
Product line cost of goods sold	4,493,125	5,296,530	14,650,910	17,347,026
Operating income (loss)	(2,172,119)	415,868	(4,638,761)	2,815,797
Depreciation and amortization	168,385	111,987	477,285	350,198
Capital expenditures	266,747	474,590	884,030	1,250,296
Product Line [Member]
Summary Information by Reportable Segment [Abstract]
Product line cost of goods sold	3,485,580	4,723,850	11,974,485	15,256,320
Product line gross profit	3,156,219	5,027,985	12,407,518	18,528,961
Finished Jewelry [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	5,321,301	7,420,591	19,297,915	23,646,044
Product line cost of goods sold	2,840,321	3,709,864	9,632,352	10,748,323
Product line gross profit	2,480,980	3,710,727	9,665,563	12,897,721
Loose Jewels [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	1,320,498	2,331,244	5,084,088	10,139,237
Product line cost of goods sold	645,259	1,013,986	2,342,133	4,507,997
Product line gross profit	675,239	1,317,258	2,741,955	5,631,240
Operating and Reportable Segments [Member] | Online Channels [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	4,616,398	6,354,814	17,314,712	21,048,274
Product line cost of goods sold	2,077,649	2,790,666	7,919,941	8,582,731
Product line gross profit	2,538,749	3,564,148	9,394,771	12,465,543
Operating income (loss)	(999,028)	350,276	(1,954,975)	2,104,674
Depreciation and amortization	47,876	52,613	167,769	173,786
Capital expenditures	14,202	28,145	173,810	114,445
Operating and Reportable Segments [Member] | Online Channels [Member] | Finished Jewelry [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	4,130,314	5,720,197	15,657,343	18,659,690
Product line cost of goods sold	1,880,504	2,560,952	7,296,812	7,705,127
Product line gross profit	2,249,810	3,159,245	8,360,531	10,954,563
Operating and Reportable Segments [Member] | Online Channels [Member] | Loose Jewels [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	486,084	634,617	1,657,369	2,388,584
Product line cost of goods sold	197,145	229,714	623,129	877,604
Product line gross profit	288,939	404,903	1,034,240	1,510,980
Operating and Reportable Segments [Member] | Traditional [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	2,025,401	3,397,021	7,067,291	12,737,007
Product line cost of goods sold	1,407,931	1,933,184	4,054,544	6,673,589
Product line gross profit	617,470	1,463,837	3,012,747	6,063,418
Operating income (loss)	(1,173,091)	65,592	(2,683,786)	711,123
Depreciation and amortization	120,509	59,374	309,516	176,412
Capital expenditures	252,545	446,445	710,220	1,135,851
Operating and Reportable Segments [Member] | Traditional [Member] | Finished Jewelry [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	1,190,987	1,700,394	3,640,572	4,986,354
Product line cost of goods sold	959,817	1,148,912	2,335,540	3,043,196
Product line gross profit	231,170	551,482	1,305,032	1,943,158
Operating and Reportable Segments [Member] | Traditional [Member] | Loose Jewels [Member]
Summary Information by Reportable Segment [Abstract]
Net sales	834,414	1,696,627	3,426,719	7,750,653
Product line cost of goods sold	448,114	784,272	1,719,004	3,630,393
Product line gross profit	$ 386,300	$ 912,355	$ 1,707,715	$ 4,120,260

XML

SEGMENT INFORMATION AND GEOGRAPHIC DATA, Reconciliation of Cost of Goods Sold (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Reconciliation of Cost of Goods Sold [Abstract]
Cost of goods sold	$ 4,493,125	$ 5,296,530	$ 14,650,910	$ 17,347,026
Inventory write-downs			119,000	232,000
Product Line [Member]
Reconciliation of Cost of Goods Sold [Abstract]
Cost of goods sold	3,485,580	4,723,850	11,974,485	15,256,320
Segment Reconciling Item [Member]
Reconciliation of Cost of Goods Sold [Abstract]
Non-capitalized manufacturing and production control expenses	596,344	484,299	1,660,231	1,243,528
Freight out	216,817	294,143	851,171	976,855
Inventory write-downs	0	0	119,000	232,000
Other inventory adjustments	$ 194,384	$ (205,762)	$ 46,023	$ (361,677)

XML

SEGMENT INFORMATION AND GEOGRAPHIC DATA, Net Sales by Geographic Area (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Net Sales by Geographic Area [Abstract]
Net sales	$ 6,641,799	$ 9,751,835	$ 24,382,003	$ 33,785,281
Reportable Geographical Component [Member] | United States [Member]
Net Sales by Geographic Area [Abstract]
Net sales	6,545,336	9,390,774	23,630,410	32,237,221
Reportable Geographical Component [Member] | International [Member]
Net Sales by Geographic Area [Abstract]
Net sales	$ 96,463	$ 361,061	$ 751,593	$ 1,548,060

XML

FAIR VALUE MEASUREMENTS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
FAIR VALUE MEASUREMENTS [Abstract]
Asset impairment	$ 0	$ 0	$ 0	$ 0

XML

INVENTORIES (Details) - USD ($)	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Inventories [Abstract]
Total supplies inventory	$ 376,830	$ 89,120
Total inventory	33,329,286	33,512,800
Short-term portion	7,889,917	11,024,276
Long-term portion	25,439,369	22,488,524
Work-in-process inventories issued to active production jobs	$ 1,410,000	2,760,000
Percentage of jewel inventory not mounted in finished jewelry settings	50.00%
Finished Jewelry [Member]
Inventories [Abstract]
Raw materials	$ 1,359,919	1,697,361
Work-in-process	716,494	1,260,728
Finished goods	13,045,604	12,100,910
Finished goods on consignment	2,266,501	2,135,856
Total	17,388,518	17,194,855
Loose Jewels [Member]
Inventories [Abstract]
Raw materials	812,024	1,985,355
Work-in-process	8,980,285	8,485,713
Finished goods	5,519,936	5,454,266
Finished goods on consignment	251,693	303,491
Total	$ 15,563,938	$ 16,228,825

XML

NOTE RECEIVABLE (Details) - Convertible Promissory Note [Member] - USD ($)	Mar. 31, 2023	Mar. 05, 2021
Note Receivable [Abstract]
Note receivable		$ 250,000
Interest rate	0.14%
Interest rate during event of default	5.00%
Percentage of per unit price of units purchased by investors	80.00%
Value used to compute equity securities received upon conversion	$ 33,500,000

XML

ACCRUED EXPENSES AND OTHER LIABILITIES (Details) - USD ($)	Mar. 31, 2023	Jun. 30, 2022
ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]
Deferred revenue	$ 434,132	$ 452,866
Accrued compensation and related benefits	275,465	614,443
Accrued sales taxes and franchise taxes	233,351	341,706
Accrued cooperative advertising	200,243	137,467
Other accrued expenses	1	1
Total accrued expenses and other liabilities	$ 1,143,192	$ 1,546,483

XML

INCOME TAXES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
INCOME TAXES [Abstract]
Income tax expense	$ 6,293,048	$ 78,480	$ 5,858,155	$ 484,582
Effective tax rate			(131.06%)	17.20%

XML

COMMITMENTS AND CONTINGENCIES, Lease Arrangements (Details)		3 Months Ended		9 Months Ended
	Jan. 29, 2021 USD ($)	Mar. 31, 2023 USD ($) ft²	Mar. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) ft²	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)
COMMITMENTS AND CONTINGENCIES [Abstract]
Area leased under operating lease | ft²		36,350		36,350
Period of extension on option		5 years		5 years
Minimum notice period for extension of lease term				270 days
Rent abatement	$ 214,000
Allowance for leasehold improvements	$ 545,000
Reimbursement for leasehold improvements		$ 506,000		$ 506,000
Balance Sheet Classifications of Leases [Abstract]
Noncurrent operating lease ROU assets		2,336,334		2,336,334		$ 2,787,419
Operating Lease Liabilities [Abstract]
Current operating lease liabilities		874,177		874,177		856,571
Noncurrent operating lease liabilities		2,251,581		2,251,581		2,846,805
Total operating lease liabilities		3,125,758		3,125,758
Operating lease cost		$ 193,000	$ 193,000	$ 578,000	$ 596,000
Assumed discount rate		2.81%		2.81%
Remaining operating lease term		3 years 6 months 29 days		3 years 6 months 29 days
Future Lease Payments Under Operating Leases [Abstract]
2023		$ 219,393		$ 219,393
2024		893,660		893,660
2025		918,236		918,236
2026		943,487		943,487
2027		317,327		317,327
Total lease payments		3,292,103		3,292,103
Less: imputed interest		166,345		166,345
Total operating lease liabilities		3,125,758		3,125,758
Less: current lease liability		874,177		874,177		856,571
Total long-term lease liability		2,251,581		2,251,581		$ 2,846,805
Cash paid for operating leases		$ 237,000	$ 160,000	$ 704,000	$ 330,000

XML

COMMITMENTS AND CONTINGENCIES, Purchase Commitments (Details) - SiC Materials [Member] $ in Thousands	6 Months Ended	9 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2023 USD ($) Option	Mar. 31, 2022 USD ($)
Purchase Commitments [Abstract]
Percentage of materials committed to be purchased		100.00%
Number of options to extend term of exclusive supply agreement | Option		1
Extension period of exclusive supply agreement		2 years
Total purchase commitment	$ 52,950	$ 52,950
Remaining purchase commitment	24,750	24,750
Purchases	0	1,800	$ 4,490
Minimum [Member]
Purchase Commitments [Abstract]
Future minimum annual purchase commitments	4,000	4,000
Maximum [Member]
Purchase Commitments [Abstract]
Future minimum annual purchase commitments	$ 10,000	$ 10,000

XML

DEBT (Details) - USD ($)	1 Months Ended	9 Months Ended
	Jul. 27, 2022	Mar. 31, 2023
Line of Credit [Abstract]
Long-term debt		$ 0
JPMorgan Chase Credit Facility [Member]
Line of Credit [Abstract]
Borrowing capacity		5,000,000
Cash deposit		$ 5,050,000.00
Interest rate premium in excess of rate otherwise applicable charged during an event of default		3.00%
Credit facility outstanding		$ 0
JPMorgan Chase Credit Facility [Member] | SOFR Rate [Member]
Line of Credit [Abstract]
Basis spread on variable rate		1.25%
Interest rate adjustment		0.10%
JPMorgan Chase Credit Facility [Member] | LIBOR [Member]
Line of Credit [Abstract]
Basis spread on variable rate	1.25%

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Repurchases of Common Stock (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2023	Jun. 30, 2022	Apr. 29, 2022
Repurchases of Common Stock [Abstract]
Period over which common stock can be repurchased			3 years
Common stock, par value (in dollars per share)	$ 0		$ 0	$ 0
Repurchases of common stock (in shares)	0		358,116
Repurchases of common stock		$ 451,815	$ 451,815
Maximum [Member]
Repurchases of Common Stock [Abstract]
Authorized amount of common stock that can be repurchased					$ 5,000,000

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Dividends (Details)	9 Months Ended
	Mar. 31, 2023 USD ($)
Dividends [Abstract]
Cash dividends	$ 0

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Stock-Based Compensation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Stock-Based Compensation [Abstract]
Stock-based compensation expense	$ 34,594	$ 198,523	$ 209,319	$ 676,934
Stock-based compensation capitalized as a cost of inventory	0	0	0	0
Employee Stock Options [Member]
Stock-Based Compensation [Abstract]
Stock-based compensation expense	63,383	60,045	185,585	187,059
Restricted Stock Awards [Member]
Stock-Based Compensation [Abstract]
Stock-based compensation expense	$ (28,789)	$ 138,478	$ 23,734	$ 489,875

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Stock Option Activity (Details) - Stock Options [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Stock Option Activity [Roll Forward]
Outstanding, beginning balance (in shares)	1,658,803
Granted (in shares)	270,787
Forfeited (in shares)	(22,004)
Expired (in shares)	(3,663)
Outstanding, ending balance (in shares)	1,903,923
Weighted Average Exercise Price [Roll Forward]
Outstanding, beginning balance (in dollars per share)	$ 1.32
Granted (in dollars per share)	1.02
Forfeited (in dollars per share)	2.01
Expired (in dollars per share)	1.01
Outstanding, ending balance (in dollars per share)	1.27
Fair Value of Stock Options [Abstract]
Fair value of stock options (in dollars per share)	$ 0.59	$ 1.37
Fair value of stock options vested	$ 225	$ 188

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Stock Options Outstanding (Details) - Stock Options [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Stock Options Outstanding and Exercisable [Abstract]
Options outstanding, balance as of end of period (in shares)	1,903,923		1,658,803
Options outstanding, weighted average remaining contractual life	6 years 7 months 9 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 1.27		$ 1.32
Options exercisable, balance as of end of period (in shares)	1,440,913
Options exercisable, weighted average remaining contractual life	5 years 9 months 21 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 1.24
Options Vested or Expected to Vest [Abstract]
Options vested or expected to vest, balance as of end of period (in shares)	1,859,855
Options vested or expected to vest, weighted average remaining contractual life	6 years 6 months 21 days
Options vested or expected to vest, weighted average exercise price (in dollars per share)	$ 1.26
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense	$ 256
Unrecognized stock-based compensation expense, period for recognition	18 months
Options outstanding, aggregate intrinsic value	$ 101	$ 973
Options exercisable, aggregate intrinsic value	101	973
Options vested or expected to vest, aggregate intrinsic value	$ 101	973
Exercised (in shares)	0
Options exercised, aggregate intrinsic value		829
Tax benefit associated with stock options exercised		$ 93

XML

SHAREHOLDERS' EQUITY AND STOCK-BASED COMPENSATION, Restricted Stock Activity (Details) - Restricted Stock [Member] $ / shares in Units, $ in Thousands	9 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Restricted Stock Activity [Roll Forward]
Unvested, beginning balance (in shares) | shares	178,750
Granted (in shares) | shares	178,750
Vested (in shares) | shares	(134,063)
Canceled (in shares) | shares	(44,687)
Unvested, ending balance (in shares) | shares	178,750
Weighted Average Grant Date Fair Value [Roll Forward]
Unvested, beginning balance (in dollars per share) | $ / shares	$ 2.75
Granted (in dollars per share) | $ / shares	0.97
Vested (in dollars per share) | $ / shares	2.75
Canceled (in dollars per share) | $ / shares	2.75
Unvested, ending balance (in dollars per share) | $ / shares	$ 0.97
Unrecognized Stock-Based Compensation Expense [Abstract]
Unrecognized stock-based compensation expense | $	$ 173
Unrecognized stock-based compensation expense, period for recognition	4 months

XML

NET (LOSS) INCOME PER COMMON SHARE (Details) - USD ($)	3 Months Ended						9 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2023	Mar. 31, 2022
Numerator [Abstract]
Net (loss) income	$ (8,396,008)	$ (1,041,781)	$ (890,192)	$ 338,508	$ 1,167,612	$ 827,025	$ (10,327,981)	$ 2,333,145
Denominator [Abstract]
Weighted average common shares outstanding, Basic (in shares)	30,344,954			30,484,897			30,387,303	30,286,195
Effect of dilutive securities (in shares)	0			783,513			0	985,482
Weighted average common shares outstanding, Diluted (in shares)	30,344,954			31,268,410			30,387,303	31,271,677
Net (Loss) Income Per Common Share [Abstract]
Basic (in dollars per share)	$ (0.28)			$ 0.01			$ (0.34)	$ 0.08
Diluted (in dollars per share)	$ (0.28)			$ 0.01			$ (0.34)	$ 0.07
Stock Options [Member]
Net Income per Common Share [Abstract]
Shares excluded from the computation of diluted net income per common share (in shares)	1,900,000			975,000			1,900,000	773,000
Restricted Stock [Member]
Net Income per Common Share [Abstract]
Unvested restricted stock outstanding (in shares)	179,000			179,000			179,000	179,000

XML

MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK (Details)	3 Months Ended		9 Months Ended			12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023		Mar. 31, 2022	Jun. 30, 2022
Minimum [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Payment terms on trade receivables			30 days
Maximum [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Payment terms on trade receivables			90 days
Trade Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Concentration risk, percentage			24.00%			20.00%
Trade Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer B [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Concentration risk, percentage			18.00%			29.00%
Trade Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer C [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Concentration risk, percentage			15.00%				[1]
Trade Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer D [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Concentration risk, percentage				[2]		13.00%
Total Net Sales [Member] | Customer Concentration Risk [Member] | Customer A [Member]
Major Customers and Concentration of Credit Risk [Abstract]
Concentration risk, percentage	13.00%	13.00%	14.00%		15.00%

[1] Customer C did not have individual balances that represented 10% or more of total gross accounts receivable as of June 30, 2022.

[2] Customer D did not have individual balances that represented 10% or more of total gross accounts receivable as of March 31, 2023.